OCA-B	B-protein
is	O
a	O
functional	O
analog	O
of	O
VP16	B-protein
but	O
targets	O
a	O
separate	O
surface	O
of	O
the	O
Oct-1	B-protein
POU	I-protein
domain	I-protein
[	O
published	O
erratum	O
appears	O
in	O
Mol	O
Cell	O
Biol	O
1998	O
Apr	O
;	O
18	O
(	O
4	O
)	O
:	O
2430	O
]	O

OCA-B	B-protein
is	O
a	O
B-cell-specific	B-protein
coregulator	I-protein
of	O
the	O
broadly	O
expressed	O
POU	B-protein
domain	I-protein
transcription	I-protein
factor	I-protein
Oct-1	B-protein
.	O

OCA-B	B-protein
associates	O
with	O
the	O
Oct-1	B-protein
POU	I-protein
domain	I-protein
,	O
a	O
bipartite	O
DNA-binding	O
structure	O
containing	O
a	O
POU-specific	B-protein
(	I-protein
POU	I-protein
[	I-protein
S	I-protein
]	I-protein
)	I-protein
domain	I-protein
joined	O
by	O
a	O
flexible	O
linker	O
to	O
a	O
POU	B-protein
homeodomain	I-protein
(	O
POU	B-protein
[	I-protein
H	I-protein
]	I-protein
)	O
.	O

Here	O
,	O
we	O
show	O
that	O
OCA-B	B-protein
alters	O
the	O
activity	O
of	O
Oct-1	B-protein
in	O
two	O
ways	O
.	O

It	O
provides	O
a	O
transcriptional	O
activation	O
domain	O
which	O
,	O
unlike	O
Oct-1	B-protein
,	O
activates	O
an	O
mRNA-type	B-DNA
promoter	I-DNA
effectively	O
,	O
and	O
it	O
stabilizes	O
Oct-1	B-protein
on	O
the	O
Oct-1-responsive	B-DNA
octamer	I-DNA
sequence	I-DNA
ATGCAAAT	O
.	O

These	O
properties	O
of	O
OCA-B	B-protein
parallel	O
those	O
displayed	O
by	O
the	O
herpes	B-protein
simplex	I-protein
virus	I-protein
Oct-1	I-protein
coregulator	I-protein
VP16	B-protein
.	O

OCA-B	B-protein
,	O
however	O
,	O
interacts	O
with	O
a	O
different	O
surface	O
of	O
the	O
DNA-bound	O
Oct-1	B-protein
POU	I-protein
domain	I-protein
,	O
interacting	O
with	O
both	O
the	O
POU	B-protein
(	I-protein
S	I-protein
)	I-protein
and	I-protein
POU	I-protein
(	I-protein
H	I-protein
)	I-protein
domains	I-protein
and	O
the	O
center	O
of	O
the	O
ATGCAAAT	B-DNA
octamer	I-DNA
sequence	I-DNA
.	O

The	O
OCA-B	O
and	O
VP16	B-protein
interactions	O
with	O
the	O
Oct-1	B-protein
POU	I-protein
domain	I-protein
are	O
sufficiently	O
different	O
to	O
permit	O
OCA-B	B-protein
and	O
VP16	B-protein
to	O
bind	O
the	O
Oct-1	B-protein
POU	I-protein
domain	I-protein
simultaneously	O
.	O

These	O
results	O
emphasize	O
the	O
structural	O
versatility	O
of	O
the	O
Oct-1	B-protein
POU	I-protein
domain	I-protein
in	O
its	O
interaction	O
with	O
coregulators	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Dec.	NULL
1997	NULL
,	NULL
p.	NULL
7295-7305	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

12	NULL
OCA-B	NULL
Is	NULL
a	NULL
Functional	NULL
Analog	NULL
of	NULL
VP16	NULL
but	NULL
Targets	NULL
a	NULL
Separate	NULL
Surface	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
Domain	NULL
ROBERT	NULL
BABB	NULL
,	NULL
*	NULL
``	NULL
MICHELE	NULL
A.	NULL
CLEARY	NULL
,	NULL
'¢	NULL
anp	NULL
WINSHIP	NULL
HERR	NULL
!	NULL

*	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
New	NULL
York	NULL
11724	NULL
,	NULL
``	NULL
and	NULL
Graduate	NULL
Program	NULL
in	NULL
Genetics	NULL
,	NULL
State	NULL
University	NULL
of	NULL
New	NULL
York	NULL
at	NULL
Stony	NULL
Brook	NULL
,	NULL
Stony	NULL
Brook	NULL
,	NULL
New	NULL
York	NULL
11794	NULL
``	NULL
Received	NULL
7	NULL
July	NULL
1997/Returned	NULL
for	NULL
modification	NULL
15	NULL
August	NULL
1997/Accepted	NULL
9	NULL
September	NULL
1997	NULL
OCA-B	NULL
is	NULL
a	NULL
B-cell-specific	NULL
coregulator	NULL
of	NULL
the	NULL
broadly	NULL
expressed	NULL
POU	NULL
domain	NULL
transcription	NULL
factor	NULL
Oct-1	NULL
.	NULL

OCA-B	NULL
associates	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
a	NULL
bipartite	NULL
DNA-binding	NULL
structure	NULL
containing	NULL
a	NULL
POU-specific	NULL
(	NULL
POU	NULL
,	NULL
)	NULL
domain	NULL
joined	NULL
by	NULL
a	NULL
flexible	NULL
linker	NULL
to	NULL
a	NULL
POU	NULL
homeodomain	NULL
(	NULL
POU	NULL
,	NULL
,	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
OCA-B	NULL
alters	NULL
the	NULL
activity	NULL
of	NULL
Oct-1	NULL
in	NULL
two	NULL
ways	NULL
.	NULL

It	NULL
provides	NULL
a	NULL
transcriptional	NULL
activation	NULL
domain	NULL
which	NULL
,	NULL
unlike	NULL
Oct-1	NULL
,	NULL
activates	NULL
an	NULL
mRNA-type	NULL
promoter	NULL
effectively	NULL
,	NULL
and	NULL
it	NULL
stabilizes	NULL
Oct-l1	NULL
on	NULL
the	NULL
Oct-l-responsive	NULL
octamer	NULL
sequence	NULL
ATGCAAAT	NULL
.	NULL

These	NULL
properties	NULL
of	NULL
OCA-B	NULL
parallel	NULL
those	NULL
displayed	NULL
by	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
Oct-1	NULL
coregulator	NULL
VP16	NULL
.	NULL

OCA-B	NULL
,	NULL
however	NULL
,	NULL
interacts	NULL
with	NULL
a	NULL
different	NULL
surface	NULL
of	NULL
the	NULL
DNA-bound	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
interacting	NULL
with	NULL
both	NULL
the	NULL
POU	NULL
and	NULL
POU	NULL
,	NULL
domains	NULL
and	NULL
the	NULL
center	NULL
of	NULL
the	NULL
ATGCAAAT	NULL
octamer	NULL
sequence	NULL
.	NULL

The	NULL
OCA-B	NULL
and	NULL
VP16	NULL
interactions	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
are	NULL
sufficiently	NULL
different	NULL
to	NULL
permit	NULL
OCA-B	NULL
and	NULL
VP16	NULL
to	NULL
bind	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
simultaneously	NULL
.	NULL

These	NULL
results	NULL
emphasize	NULL
the	NULL
structural	NULL
versatility	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
in	NULL
its	NULL
interaction	NULL
with	NULL
coregulators	NULL
.	NULL

In	NULL
eukaryotes	NULL
,	NULL
the	NULL
activities	NULL
of	NULL
transcriptional	NULL
activators	NULL
can	NULL
be	NULL
modified	NULL
by	NULL
coregulators	NULL
,	NULL
thus	NULL
providing	NULL
flexibility	NULL
and	NULL
diversity	NULL
in	NULL
transcriptional	NULL
regulation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
broadly	NULL
expressed	NULL
human	NULL
POU	NULL
domain	NULL
transcription	NULL
factor	NULL
Oct-1	NULL
acquires	NULL
cell-specific	NULL
promoter	NULL
activation	NULL
properties	NULL
through	NULL
association	NULL
with	NULL
both	NULL
viral	NULL
and	NULL
cellular	NULL
coregulators	NULL
.	NULL

In	NULL
herpes	NULL
simplex	NULL
virus	NULL
(	NULL
HSV	NULL
)	NULL
-infected	NULL
cells	NULL
,	NULL
HSV	NULL
virion	NULL
protein	NULL
VP16	NULL
(	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
Vmw65	NULL
and	NULL
«	NULL
TIF	NULL
)	NULL
activates	NULL
HSV	NULL
immediate-early	NULL
gene	NULL
transcription	NULL
by	NULL
directing	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
multiprotein-DNA	NULL
complex	NULL
with	NULL
Oct-1	NULL
and	NULL
another	NULL
cellular	NULL
protein	NULL
,	NULL
HCF	NULL
(	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
C1	NULL
,	NULL
VCAF	NULL
,	NULL
and	NULL
CFF	NULL
)	NULL
on	NULL
VP16-responsive	NULL
TAATGARAT	NULL
elements	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
18	NULL
,	NULL
36	NULL
,	NULL
and	NULL
54	NULL
)	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
,	NULL
Oct-1	NULL
associates	NULL
with	NULL
the	NULL
cellular	NULL
transactivator	NULL
OCA-B	NULL
(	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
OBF-1	NULL
and	NULL
Bob-1	NULL
)	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
octamer	NULL
(	NULL
ATGCAAAT	NULL
)	NULL
elements	NULL
in	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
gene	NULL
promoters	NULL
(	NULL
17	NULL
,	NULL
29	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Oct-1	NULL
binds	NULL
to	NULL
a	NULL
diverse	NULL
range	NULL
of	NULL
cis-regulatory	NULL
DNA	NULL
sequences	NULL
through	NULL
its	NULL
DNA-binding	NULL
POU	NULL
domain	NULL
,	NULL
a	NULL
bipartite	NULL
structure	NULL
consisting	NULL
of	NULL
an	NULL
amino-terminal	NULL
POU-specific	NULL
(	NULL
POU	NULL
)	NULL
domain	NULL
joined	NULL
by	NULL
a	NULL
flexible	NULL
linker	NULL
to	NULL
a	NULL
carboxy-terminal	NULL
POU	NULL
homeodomain	NULL
(	NULL
POU	NULL
,	NULL
;	NULL
)	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
18	NULL
and	NULL
42	NULL
)	NULL
.	NULL

High-affinity	NULL
Oct-1-binding	NULL
sites	NULL
include	NULL
the	NULL
octamer	NULL
sequence	NULL
found	NULL
in	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
promoters	NULL
,	NULL
such	NULL
as	NULL
the	NULL
broadly	NULL
expressed	NULL
histone	NULL
H2B	NULL
and	NULL
small	NULL
nuclear	NULL
RNA	NULL
(	NULL
snRNA	NULL
)	NULL
promoters	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
Oct-1-binding	NULL
sites	NULL
in	NULL
snRNA	NULL
promoters	NULL
,	NULL
Oct-1	NULL
contains	NULL
activation	NULL
domains	NULL
which	NULL
activate	NULL
transcription	NULL
from	NULL
snRNA	NULL
promoters	NULL
preferentially	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
many	NULL
activation	NULL
domains	NULL
activate	NULL
transcription	NULL
from	NULL
mRNA	NULL
promoters	NULL
preferentially	NULL
(	NULL
10	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Both	NULL
VP16	NULL
(	NULL
24	NULL
,	NULL
47	NULL
)	NULL
and	NULL
OCA-B	NULL
(	NULL
17	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
interact	NULL
with	NULL
Oct-1	NULL
through	NULL
its	NULL
POU	NULL
domain	NULL
.	NULL

VP16	NULL
recognizes	NULL
residues	NULL
on	NULL
the	NULL
solvent-exposed	NULL
surface	NULL
of	NULL
the	NULL
DNA-bound	NULL
Oct-1	NULL
POU	NULL
;	NULL
domain	NULL
(	NULL
25	NULL
,	NULL
40	NULL
,	NULL
47	NULL
)	NULL
and	NULL
alters	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
Oct-1	NULL
in	NULL
two	NULL
ways	NULL
,	NULL
(	NULL
i	NULL
)	NULL
by	NULL
providing	NULL
a	NULL
transcriptional	NULL
activation	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
516	NULL
)	NULL
367-8401	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
516	NULL
)	NULL
367-8454	NULL
.	NULL

E-mail	NULL
:	NULL
herr	NULL
@	NULL
cshl.org	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Princeton	NULL
University	NULL
,	NULL
Princeton	NULL
,	NULL
NJ	NULL
08544	NULL
.	NULL

7295	NULL
domain	NULL
which	NULL
activates	NULL
mRNA	NULL
promoters	NULL
preferentially	NULL
(	NULL
10	NULL
)	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
by	NULL
stabilizing	NULL
Oct-1	NULL
on	NULL
VP16-responsive	NULL
elements	NULL
(	NULL
5	NULL
)	NULL
.	NULL

OCA-B	NULL
also	NULL
stimulates	NULL
the	NULL
activation	NULL
of	NULL
mRNA-type	NULL
promoters	NULL
by	NULL
Oct-1	NULL
(	NULL
17	NULL
,	NULL
29	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
,	NULL
but	NULL
the	NULL
requirements	NULL
for	NULL
OCA-B	NULL
interaction	NULL
with	NULL
Oct-1	NULL
and	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
this	NULL
interaction	NULL
on	NULL
the	NULL
activities	NULL
of	NULL
Oct-1	NULL
have	NULL
not	NULL
been	NULL
extensively	NULL
characterized	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
functional	NULL
properties	NULL
of	NULL
OCA-B	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
OCA-B	NULL
functions	NULL
analogously	NULL
to	NULL
VP16	NULL
.	NULL

OCA-B	NULL
contains	NULL
an	NULL
activation	NULL
domain	NULL
which	NULL
preferentially	NULL
activates	NULL
mRNA-type	NULL
promoters	NULL
,	NULL
and	NULL
OCA-B	NULL
can	NULL
stabilize	NULL
Oct-1	NULL
binding	NULL
to	NULL
a	NULL
cis-regulatory	NULL
site	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
VP16	NULL
,	NULL
however	NULL
,	NULL
OCA-B	NULL
recognizes	NULL
a	NULL
separate	NULL
surface	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reporter	NULL
plasmids	NULL
.	NULL

Reporter	NULL
constructs	NULL
pc-fos/-197/4xG17M	NULL
and	NULL
pU2/-198/	NULL
4xG17M	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
.	NULL

For	NULL
the	NULL
in	NULL
vivo	NULL
corecruitment	NULL
assay	NULL
,	NULL
two	NULL
tandem	NULL
copies	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
As-T	NULL
(	NULL
ATGCITAAT	NULL
)	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
octamer	NULL
sites	NULL
(	NULL
38	NULL
)	NULL
separated	NULL
by	NULL
Xho	NULL
!	NULL

recognition	NULL
sequences	NULL
,	NULL
GAGGAGCATG	NULL
CAAATCATTGGCTC	NULL
,	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
Sme	NULL
site	NULL
of	NULL
pU2/B	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Effector	NULL
plasmids	NULL
.	NULL

Full-length	NULL
human	NULL
OCA-B	NULL
coding	NULL
sequences	NULL
were	NULL
amplified	NULL
from	NULL
B-JAB	NULL
cell	NULL
RNA	NULL
by	NULL
reverse	NULL
transcriptase	NULL
PCR	NULL
with	NULL
primers	NULL
,	NULL
5°	NULL
CAT	NULL
CTAGACTCTGGCAAAAACCCACAGC	NULL
(	NULL
OBFNXBA	NULL
)	NULL
and	NULL
3	NULL
'	NULL
CAGGATCC	NULL
TAAAAGCCTTCCACAGAG	NULL
(	NULL
OBFCBAM	NULL
)	NULL
,	NULL
containing	NULL
Xbel	NULL
and	NULL
BamHI	NULL
sites	NULL
(	NULL
underlined	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
sequences	NULL
were	NULL
inserted	NULL
between	NULL
the	NULL
Xbal	NULL
and	NULL
BamHI	NULL
sites	NULL
of	NULL
the	NULL
hemagglutinin	NULL
epitope	NULL
tag-cytomegalovirus	NULL
promoter	NULL
expression	NULL
vector	NULL
pCGN	NULL
(	NULL
52	NULL
)	NULL
,	NULL
creating	NULL
pCGN-OCA-B	NULL
.	NULL

pCGN-OCA-BAC	NULL
was	NULL
prepared	NULL
via	NULL
PCR	NULL
amplification	NULL
of	NULL
sequences	NULL
encoding	NULL
OCA-B	NULL
residues	NULL
1	NULL
to	NULL
119.	NULL
pCGN-Oct-1-POU	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
pCG-Oct-1-POU	NULL
(	NULL
25	NULL
)	NULL
that	NULL
contains	NULL
the	NULL
hemagglutinin	NULL
epitope	NULL
tag	NULL
.	NULL

pCGN-POU-VP16	NULL
was	NULL
created	NULL
by	NULL
the	NULL
insertion	NULL
of	NULL
sequences	NULL
encoding	NULL
the	NULL
VP16	NULL
activation	NULL
domain	NULL
(	NULL
residues	NULL
413	NULL
to	NULL
490	NULL
)	NULL
,	NULL
flanked	NULL
by	NULL
5°	NULL
Xbel	NULL
and	NULL
3	NULL
'	NULL
Nhe	NULL
!	NULL

sites	NULL
,	NULL
into	NULL
the	NULL
Xbel	NULL
site	NULL
of	NULL
pCGN-Oct-1-POU	NULL
5	NULL
'	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
coding	NULL
sequences	NULL
.	NULL

pCGN-POUs-g-VP16	NULL
was	NULL
created	NULL
by	NULL
oligonucleotide-mediated	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
GAL4	NULL
fusion	NULL
activators	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
,	NULL
except	NULL
for	NULL
pCG-GALA	NULL
(	NULL
1-94	NULL
)	NULL
-OCA-B1z0	NULL
256	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
sequences	NULL
encoding	NULL
OCA-B	NULL
residues	NULL
120	NULL
to	NULL
256	NULL
.	NULL

All	NULL
effector	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

POU	NULL
domain	NULL
mutagenesis	NULL
.	NULL

The	NULL
Oct-1	NULL
and	NULL
Pit-1	NULL
POU	NULL
,	NULL
domain	NULL
,	NULL
linker	NULL
,	NULL
and	NULL
POU	NULL
,	NULL
domain	NULL
chimeras	NULL
PPOO	NULL
,	NULL
OOPO	NULL
,	NULL
and	NULL
OOOP	NULL
(	NULL
1	NULL
)	NULL
;	NULL
POU	NULL
,	NULL
domain	NULL
chimeras	NULL
EIR-1	NULL
,	NULL
NEV-1	NULL
,	NULL
TNE-2	NULL
,	NULL
DSE	NULL
,	NULL
L6I	NULL
,	NULL
E7R	NULL
,	NULL
and	NULL
Pit-1	NULL
R7E	NULL
(	NULL
32	NULL
)	NULL
;	NULL
single	NULL
POU	NULL
,	NULL
alanine	NULL
substitution	NULL
R49A	NULL
(	NULL
6	NULL
)	NULL
;	NULL
and	NULL
POU	NULL
;	NULL
alanine	NULL
substitution	NULL
E22A	NULL
(	NULL
25	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

Mutant	NULL
POU	NULL
domain	NULL
proteins	NULL
were	NULL
gen-crated	NULL
by	NULL
oligonucleotide-mediated	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
plasmid	NULL
pET11c.G.POU-1	NULL
(	NULL
25	NULL
)	NULL
,	NULL
which	NULL
encodes	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
gene	NULL
product	NULL
.	NULL

Double-mutant	NULL
POU	NULL
domain	NULL
proteins	NULL
(	NULL
POUsp	NULL
;	NULL
gq	NULL
POUzp	NULL
>	NULL
za	NULL
and	NULL
POUs.gigcyasn	NULL
)	NULL
were	NULL
made	NULL
by	NULL
two	NULL
suc-	NULL
7296	NULL
BABB	NULL
ET	NULL
AL	NULL
.	NULL

cessive	NULL
rounds	NULL
of	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

These	NULL
mutations	NULL
are	NULL
named	NULL
according	NULL
to	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
wild-type	NULL
amino	NULL
acid	NULL
,	NULL
followed	NULL
by	NULL
its	NULL
position	NULL
in	NULL
the	NULL
POU	NULL
;	NULL
or	NULL
POU	NULL
;	NULL
domain	NULL
and	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
amino	NULL
acid	NULL
substitution	NULL
;	NULL
thus	NULL
,	NULL
the	NULL
replacement	NULL
of	NULL
the	NULL
Oct-1	NULL
POUs	NULL
domain	NULL
glutamic	NULL
acid	NULL
at	NULL
position	NULL
7	NULL
with	NULL
arginine	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
Each	NULL
mutation	NULL
carries	NULL
a	NULL
cosegregating	NULL
restriction	NULL
site	NULL
polymorphism	NULL
,	NULL
whose	NULL
identity	NULL
is	NULL
available	NULL
upon	NULL
request	NULL
.	NULL

Mutations	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

Wild-type	NULL
and	NULL
mutant	NULL
DNA-binding	NULL
sites	NULL
.	NULL

The	NULL
H2B	NULL
octamer	NULL
site	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
site	NULL
ICPO	NULL
perfect	NULL
octamer	NULL
(	NULL
CATGCAAA	NULL
TGATATT	NULL
)	NULL
was	NULL
created	NULL
by	NULL
oligonucleotide-mediated	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
ICPO/TAAT-1	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
for	NULL
electropheretic	NULL
mobility	NULL
retardation	NULL
analysis	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
*°P-end-labeled	NULL
primers	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
probes	NULL
used	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
were	NULL
made	NULL
by	NULL
annealing	NULL
*°P-end-labeled	NULL
complementary	NULL
oligonucleotides	NULL
,	NULL
5	NULL
'	NULL
GGGGAGAGT	NULL
TCGAGGCTTATGCAAATAAGGTGCTCGAGACCTGCGC	NULL
3	NULL
'	NULL
(	NULL
H2BWT1	NULL
)	NULL
and	NULL
5°	NULL
GCGCAGGTCTCGAGCACCTTATITGCATAAGCCTCGAACTCTC	NULL
CCC	NULL
3	NULL
'	NULL
(	NULL
H2BWT2	NULL
)	NULL
.	NULL

H2B	NULL
octamer	NULL
mutant	NULL
sites	NULL
G	NULL
;	NULL
-T	NULL
,	NULL
C	NULL
,	NULL
>	NULL
T	NULL
,	NULL
As-T	NULL
,	NULL
Ag-T	NULL
,	NULL
ICs	NULL
,	NULL
and	NULL
IC	NULL
,	NULL
were	NULL
generated	NULL
by	NULL
annealing	NULL
complementary	NULL
mutant	NULL
H2BWT1-	NULL
and	NULL
H2BWT2-related	NULL
oligonucleotides	NULL
.	NULL

To	NULL
generate	NULL
DNase	NULL
I	NULL
footprinting	NULL
probe	NULL
pUC119-H2B/OCTA+Igk/OCTA	NULL
,	NULL
wild-type	NULL
or	NULL
mutant	NULL
A	NULL
,	NULL
;	NULL
-T	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
octamer	NULL
sites	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
Smel	NULL
site	NULL
of	NULL
pUC119-H2B/OCTA	NULL
(	NULL
5	NULL
)	NULL
in	NULL
such	NULL
a	NULL
way	NULL
that	NULL
both	NULL
octamer	NULL
sites	NULL
were	NULL
in	NULL
the	NULL
same	NULL
orientation	NULL
and	NULL
separated	NULL
by	NULL
33	NULL
bp	NULL
.	NULL

Probes	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
a	NULL
*°P-end-labeled	NULL
universal	NULL
sequencing	NULL
primer	NULL
and	NULL
an	NULL
unlabeled	NULL
primer	NULL
,	NULL
RSP-100	NULL
(	NULL
5'-TGTGAGTTAGCTCACT	NULL
3	NULL
'	NULL
)	NULL
,	NULL
which	NULL
anneals	NULL
to	NULL
sequences	NULL
approximately	NULL
100	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
reverse	NULL
sequencing	NULL
primer	NULL
.	NULL

Protein	NULL
expression	NULL
and	NULL
purification	NULL
.	NULL

Wild-type	NULL
and	NULL
POUs.5	NULL
;	NULL
g	NULL
GST-Oct-1	NULL
POU	NULL
domain	NULL
proteins	NULL
were	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Wild-type	NULL
and	NULL
mutant	NULL
Oct-1	NULL
POU	NULL
domains	NULL
and	NULL
OCA-B	NULL
used	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
retardation	NULL
assays	NULL
were	NULL
synthesized	NULL
in	NULL
vitro	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
6	NULL
)	NULL
.	NULL

OCA-B	NULL
for	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
was	NULL
prepared	NULL
by	NULL
overexpression	NULL
after	NULL
calcium	NULL
phosphate	NULL
coprecipitation-mediated	NULL
transfection	NULL
(	NULL
51	NULL
)	NULL
of	NULL
10°	NULL
HeLa	NULL
cells	NULL
with	NULL
16	NULL
ug	NULL
of	NULL
pCGN-OCA-B	NULL
,	NULL
followed	NULL
by	NULL
whole-cell	NULL
nuclear	NULL
extract	NULL
preparation	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
53	NULL
)	NULL
.	NULL

VP16AC	NULL
was	NULL
expressed	NULL
in	NULL
and	NULL
purified	NULL
from	NULL
£	NULL
.	NULL

coli	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
57	NULL
)	NULL
,	NULL
and	NULL
HCF4sp	NULL
(	NULL
HCF	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
450	NULL
)	NULL
(	NULL
58	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
.	NULL

In	NULL
vivo	NULL
transcription	NULL
assays	NULL
.	NULL

Transcriptional	NULL
activities	NULL
were	NULL
assayed	NULL
in	NULL
vivo	NULL
by	NULL
calcium	NULL
phosphate	NULL
coprecipitation-mediated	NULL
transfection	NULL
of	NULL
HeLa	NULL
cells	NULL
and	NULL
RNase	NULL
protection	NULL
of	NULL
isolated	NULL
RNAs	NULL
(	NULL
51	NULL
)	NULL
with	NULL
«	NULL
98	NULL
and	NULL
B134	NULL
probes	NULL
(	NULL
5	NULL
)	NULL
,	NULL
the	NULL
c-fos	NULL
probe	NULL
(	NULL
50	NULL
)	NULL
,	NULL
and	NULL
U2	NULL
probe	NULL
A	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
GALA	NULL
activation	NULL
domain	NULL
fusion	NULL
assays	NULL
(	NULL
10	NULL
)	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
GAL4	NULL
fusion	NULL
activators	NULL
was	NULL
monitored	NULL
by	NULL
electropheretic	NULL
mobility	NULL
retardation	NULL
analysis	NULL
.	NULL

All	NULL
activators	NULL
were	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
as	NULL
single	NULL
,	NULL
apparently	NULL
full-length	NULL
species	NULL
,	NULL
except	NULL
for	NULL
GALA-VP16	NULL
;	NULL
it	NULL
was	NULL
expressed	NULL
at	NULL
lower	NULL
levels	NULL
,	NULL
but	NULL
this	NULL
lower-level	NULL
expression	NULL
did	NULL
not	NULL
prevent	NULL
transcriptional	NULL
activation	NULL
.	NULL

In	NULL
the	NULL
in	NULL
vivo	NULL
Oct-1	NULL
POU	NULL
domain-OCA-B	NULL
recruitment	NULL
assay	NULL
,	NULL
640	NULL
ng	NULL
of	NULL
pCGN-Oct-1-POU	NULL
or	NULL
a	NULL
derivative	NULL
was	NULL
cotransfected	NULL
with	NULL
480	NULL
ng	NULL
of	NULL
pCGN-OCA¥-BAC	NULL
,	NULL
4	NULL
pg	NULL
of	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
160	NULL
ng	NULL
of	NULL
internal	NULL
reference	NULL
plasmid	NULL
padx	NULL
(	NULL
A+C	NULL
)	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
activities	NULL
of	NULL
the	NULL
B-globin	NULL
and	NULL
c-fos	NULL
probes	NULL
were	NULL
half	NULL
those	NULL
of	NULL
the	NULL
«	NULL
-globin	NULL
and	NULL
U2	NULL
probes	NULL
.	NULL

Unprotected	NULL
RNA	NULL
was	NULL
digested	NULL
by	NULL
RNases	NULL
A	NULL
and	NULL
T	NULL
;	NULL
,	NULL
and	NULL
protected	NULL
fragments	NULL
were	NULL
visualized	NULL
by	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
6	NULL
%	NULL
polyacrylamide	NULL
)	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
were	NULL
quantified	NULL
on	NULL
a	NULL
Fuji	NULL
BAS1000	NULL
phosphorimager	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
analysis	NULL
.	NULL

Protein-DNA	NULL
binding	NULL
was	NULL
performed	NULL
in	NULL
50-pl	NULL
reaction	NULL
mixtures	NULL
containing	NULL
2	NULL
x	NULL
10*	NULL
cpm	NULL
of	NULL
DNA	NULL
probe	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
2	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
%	NULL
Ficoll	NULL
,	NULL
3	NULL
mg	NULL
of	NULL
fetal	NULL
bovine	NULL
serum	NULL
per	NULL
ml	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
fish	NULL
sperm	NULL
DNA	NULL
,	NULL
3.2	NULL
mg	NULL
of	NULL
unsonicated	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
and	NULL
2	NULL
%	NULL
polyvinyl	NULL
alcohol	NULL
.	NULL

Purified	NULL
recombinant	NULL
GST-Oct-1	NULL
POU	NULL
domain	NULL
fusion	NULL
protein	NULL
(	NULL
13	NULL
ng	NULL
)	NULL
and	NULL
5	NULL
pl	NULL
of	NULL
either	NULL
mock-	NULL
or	NULL
OCA-B-transfected	NULL
HeLa	NULL
cell	NULL
extract	NULL
were	NULL
used	NULL
as	NULL
indicated	NULL
.	NULL

Prior	NULL
to	NULL
DNase	NULL
I	NULL
digestion	NULL
,	NULL
protein-DNA	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Reactions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
5	NULL
)	NULL
,	NULL
except	NULL
that	NULL
more	NULL
DNase	NULL
I	NULL
(	NULL
230	NULL
ng	NULL
;	NULL
Worthington	NULL
)	NULL
was	NULL
used	NULL
per	NULL
reaction	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
retardation	NULL
assays	NULL
.	NULL

Protcin-DNA	NULL
binding	NULL
reactions	NULL
(	NULL
10	NULL
pl	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
follows	NULL
.	NULL

In	NULL
vitro-translated	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
1	NULL
pl	NULL
)	NULL
,	NULL
OCA-B	NULL
(	NULL
2	NULL
wl	NULL
)	NULL
,	NULL
HCF	NULL
,	NULL
s	NULL
,	NULL
(	NULL
0.5	NULL
wl	NULL
)	NULL
,	NULL
and	NULL
E.	NULL
coli-expressed	NULL
VP16	NULL
(	NULL
40	NULL
ng	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
X	NULL
10°	NULL
cpm	NULL
DNA	NULL
probe	NULL
in	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-50	NULL
mM	NULL
KCl-2	NULL
mM	NULL
dithiothreitol-1	NULL
mM	NULL
EDTA-0.1	NULL
%	NULL
Nonidet	NULL
P-40-2	NULL
%	NULL
glycerol-2	NULL
%	NULL
Ficoll-3	NULL
mg	NULL
of	NULL
fetal	NULL
bovine	NULL
serum	NULL
per	NULL
ml-10	NULL
ng	NULL
of	NULL
fish	NULL
sperm	NULL
DNA-640	NULL
ng	NULL
of	NULL
unsonicated	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
reaction	NULL
mixtures	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
6.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
acrylamide/	NULL
bisacrylamide	NULL
ratio	NULL
,	NULL
19:1	NULL
)	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
(	NULL
22.5	NULL
mM	NULL
Tris-borate	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
which	NULL
had	NULL
been	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

For	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
full-length	NULL
HeLa	NULL
cell	NULL
Oct-1	NULL
was	NULL
200-fold	NULL
enriched	NULL
by	NULL
passage	NULL
over	NULL
wheat	NULL
germ	NULL
agglutinin	NULL
(	NULL
57	NULL
)	NULL
.	NULL

RESULTS	NULL
To	NULL
analyze	NULL
the	NULL
functional	NULL
properties	NULL
of	NULL
human	NULL
OCA-B	NULL
,	NULL
we	NULL
assayed	NULL
the	NULL
promoter-selective	NULL
properties	NULL
of	NULL
the	NULL
OCA-B	NULL
activation	NULL
domain	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
OCA-B	NULL
to	NULL
stabilize	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
on	NULL
DNA	NULL
.	NULL

We	NULL
subsequently	NULL
probed	NULL
the	NULL
surfaces	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

DNA-binding	NULL
domain	NULL
:	NULL
GAL4	NULL
(	NULL
1-94	NULL
)	NULL
GAL4	NULL
(	NULL
1-94	NULL
)	NULL
I	NULL
imm	NULL
F	NULL
imum	NULL
©	NULL
o	NULL
a	NULL
©	NULL
o	NULL
g	NULL
Activation	NULL
g	NULL
96.	NULL
gl	NULL
L	NULL
;	NULL
g	NULL
g	NULL
E	NULL
5	NULL
)	NULL
%	NULL
g	NULL
domain	NULL
:	NULL
i	NULL
i	NULL
>	NULL
&	NULL
6	NULL
8	NULL
8	NULL
1a	NULL
S	NULL
&	NULL
o	NULL
8	NULL
8	NULL
»	NULL
»	NULL
Cutt	NULL
@	NULL
@	NULL
@	NULL
-	NULL
U2	NULL
RT	NULL
c-fos	NULL
-	NULL
«	NULL
o	NULL
us	NULL
at	NULL
-	NULL
U2	NULL
1234567I891011121314	NULL
‘	NULL
mRNA	NULL
snRNA	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
properties	NULL
of	NULL
the	NULL
Oct-1	NULL
cellular	NULL
coregulator	NULL
OCA-B	NULL
with	NULL
the	NULL
viral	NULL
coregulator	NULL
VP16	NULL
.	NULL

c-fos	NULL
mRNA	NULL
(	NULL
lanes	NULL
1	NULL
through	NULL
7	NULL
)	NULL
or	NULL
U2	NULL
snRNA	NULL
(	NULL
lanes	NULL
8	NULL
through	NULL
14	NULL
)	NULL
reporter	NULL
plasmids	NULL
and	NULL
an	NULL
«	NULL
-globin	NULL
internal	NULL
reference	NULL
plasmid	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
along	NULL
with	NULL
the	NULL
appropriate	NULL
activator	NULL
expression	NULL
plasmid	NULL
,	NULL
and	NULL
RNA	NULL
expression	NULL
was	NULL
monitored	NULL
by	NULL
RNase	NULL
protection	NULL
analysis	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
GAL4	NULL
DNA-binding	NULL
domain-activation	NULL
domain	NULL
fusion	NULL
used	NULL
in	NULL
each	NULL
sample	NULL
is	NULL
indicated	NULL
above	NULL
the	NULL
corresponding	NULL
lane	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
correctly	NULL
initiated	NULL
-globin	NULL
(	NULL
a	NULL
)	NULL
,	NULL
c-fos	NULL
,	NULL
U2	NULL
,	NULL
and	NULL
U2	NULL
read-through	NULL
(	NULL
U2	NULL
RT	NULL
)	NULL
transcripts	NULL
are	NULL
indicated	NULL
.	NULL

-	NULL
,	NULL
absent	NULL
.	NULL

of	NULL
the	NULL
DNA	NULL
and	NULL
Oct-1	NULL
POU	NULL
domain	NULL
required	NULL
for	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
on	NULL
an	NULL
octamer	NULL
site	NULL
.	NULL

OCA-B	NULL
contains	NULL
an	NULL
mRNA-type	NULL
promoter-selective	NULL
activation	NULL
domain	NULL
.	NULL

Transcriptional	NULL
activation	NULL
domains	NULL
can	NULL
display	NULL
promoter	NULL
selectivity	NULL
,	NULL
distinguishing	NULL
for	NULL
example	NULL
between	NULL
mRNA-	NULL
and	NULL
snRNA-type	NULL
promoters	NULL
(	NULL
10	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
a	NULL
comparison	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
properties	NULL
of	NULL
OCA-B	NULL
(	NULL
residues	NULL
120	NULL
to	NULL
256	NULL
)	NULL
(	NULL
17	NULL
)	NULL
with	NULL
the	NULL
mRNA-type	NULL
promoter-selective	NULL
activation	NULL
domains	NULL
from	NULL
VP16	NULL
and	NULL
the	NULL
Oct-1-related	NULL
B-cell	NULL
POU	NULL
domain	NULL
activator	NULL
Oct-2	NULL
and	NULL
with	NULL
the	NULL
snRNA	NULL
promoter-selective	NULL
activation	NULL
domains	NULL
from	NULL
Oct-1	NULL
and	NULL
a	NULL
second	NULL
snRNA	NULL
promoter	NULL
activator	NULL
,	NULL
Spl	NULL
(	NULL
10	NULL
)	NULL
.	NULL

These	NULL
activation	NULL
domains	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
GALA	NULL
DNA-binding	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
94	NULL
)	NULL
and	NULL
assayed	NULL
with	NULL
c-fos	NULL
mRNA	NULL
and	NULL
UZ	NULL
snRNA	NULL
promoters	NULL
containing	NULL
GAL4-binding	NULL
sites	NULL
by	NULL
transient	NULL
expression	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

An	NULL
«	NULL
-globin	NULL
gene	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reference	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
and	NULL
correctly	NULL
initiated	NULL
transcripts	NULL
were	NULL
measured	NULL
by	NULL
RNase	NULL
protection	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
10	NULL
)	NULL
,	NULL
the	NULL
VP16-	NULL
and	NULL
Oct-2-derived	NULL
activation	NULL
domains	NULL
were	NULL
better	NULL
activators	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
and	NULL
of	NULL
an	NULL
mRNA-type	NULL
read-through	NULL
transcript	NULL
[	NULL
U2	NULL
RT	NULL
]	NULL
[	NULL
10	NULL
]	NULL
evident	NULL
with	NULL
the	NULL
UZ	NULL
snRNA	NULL
promoter	NULL
construct	NULL
[	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
8	NULL
through	NULL
14	NULL
]	NULL
)	NULL
than	NULL
were	NULL
the	NULL
Oct-1-	NULL
and	NULL
Sp1-derived	NULL
activation	NULL
domains	NULL
(	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
with	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
OCA-B	NULL
activation	NULL
domain	NULL
was	NULL
also	NULL
an	NULL
effective	NULL
activator	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
;	NULL
it	NULL
was	NULL
as	NULL
active	NULL
as	NULL
the	NULL
Oct-2-derived	NULL
activation	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
.	NULL

With	NULL
the	NULL
U2	NULL
snRNA	NULL
promoter	NULL
,	NULL
however	NULL
,	NULL
the	NULL
Oct-1-	NULL
and	NULL
Spl-derived	NULL
activation	NULL
domains	NULL
were	NULL
more	NULL
active	NULL
than	NULL
were	NULL
the	NULL
VP16-	NULL
and	NULL
Oct-2-derived	NULL
activation	NULL
domains	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
compare	NULL
lanes	NULL
10	NULL
and	NULL
14	NULL
with	NULL
lanes	NULL
11	NULL
and	NULL
13	NULL
)	NULL
and	NULL
the	NULL
OCA-B	NULL
activation	NULL
domain	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
like	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
VP16	NULL
,	NULL
the	NULL
OCA-B	NULL
activation	NULL
domain	NULL
displays	NULL
mRNA	NULL
promoter	NULL
selectivity	NULL
,	NULL
which	NULL
provides	NULL
one	NULL
explanation	NULL
as	NULL
to	NULL
how	NULL
,	NULL
by	NULL
association	NULL
with	NULL
Oct-1	NULL
,	NULL
OCA-B	NULL
can	NULL
enhance	NULL
Oct-1	NULL
activation	NULL
of	NULL
an	NULL
mRNA	NULL
promoter	NULL
(	NULL
17	NULL
,	NULL
29	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
CC	NULL
t	NULL
3	NULL
Oct-1	NULL
POU	NULL
:	NULL
-	NULL
5	NULL
_	NULL
?	NULL

-	NULL
_	NULL
E	NULL
I	NULL
1T	NULL
-	NULL
_	NULL
f	NULL
1	NULL
I	NULL
1	NULL
1	NULL
OCA-Bzg—+—+—+	NULL
-	NULL
#	NULL
0	NULL
-	NULL
+	NULL
ue	NULL
7	NULL
ho	NULL
A4	NULL
<	NULL
--	NULL
-H2B	NULL
OCTA	NULL
*	NULL
--	NULL
Igx	NULL
OCTA	NULL
see	NULL
oz	NULL
a=	NULL
fous	NULL
Aff	NULL
*	NULL
e*	NULL
Es	NULL
22	NULL
-	NULL
is	NULL
=	NULL
z*	NULL
==	NULL
Sas	NULL
-	NULL
>	NULL
ame	NULL
wus	NULL
®	NULL
s	NULL
a	NULL
C	NULL
goes	NULL
*	NULL
*	NULL
*	NULL
1	NULL
I8	NULL
9	NULL
10	NULL
11I	NULL
I234567l	NULL
WT	NULL
As	NULL
>	NULL
T	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

OCA-B	NULL
recruits	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
to	NULL
the	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
octamer	NULL
site	NULL
in	NULL
vitro	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
analysis	NULL
of	NULL
Oct-1	NULL
POU	NULL
domain	NULL
binding	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
DNA	NULL
probe	NULL
containing	NULL
the	NULL
histone	NULL
H2B	NULL
(	NULL
H2B	NULL
OCTA	NULL
)	NULL
and	NULL
Ig	NULL
(	NULL
«	NULL
)	NULL
(	NULL
Ig	NULL
«	NULL
OCTA	NULL
)	NULL
promoter	NULL
octamer	NULL
sites	NULL
.	NULL

Recombinant	NULL
wild-type	NULL
(	NULL
WT	NULL
;	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
11	NULL
)	NULL
and	NULL
POUs	NULL
;	NULL
g	NULL
mutant	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
GST-Oct-1	NULL
POU	NULL
domain	NULL
proteins	NULL
were	NULL
assayed	NULL
in	NULL
either	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
9	NULL
,	NULL
and	NULL
11	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
of	NULL
OCA-B	NULL
on	NULL
a	NULL
probe	NULL
containing	NULL
either	NULL
WT	NULL
(	NULL
lanes	NULL
2	NULL
through	NULL
7	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
As-T	NULL
;	NULL
lanes	NULL
8	NULL
through	NULL
11	NULL
)	NULL
Ig	NULL
(	NULL
«	NULL
)	NULL
octamer	NULL
sites	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
chemical	NULL
sequencing	NULL
of	NULL
the	NULL
same	NULL
probe	NULL
(	NULL
A+G	NULL
)	NULL
.	NULL

Asterisk	NULL
,	NULL
labeled	NULL
end	NULL
of	NULL
probe	NULL
.	NULL

OCA-B	NULL
enhances	NULL
binding	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
to	NULL
an	NULL
octamer	NULL
site	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

We	NULL
assayed	NULL
the	NULL
ability	NULL
of	NULL
OCA-B	NULL
to	NULL
stabilize	NULL
Oct-1	NULL
on	NULL
an	NULL
OCA-B-responsive	NULL
element	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
assay	NULL
stabilization	NULL
in	NULL
vitro	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
OCA-B	NULL
on	NULL
Oct-1	NULL
POU	NULL
domain	NULL
binding	NULL
to	NULL
a	NULL
previously	NULL
described	NULL
octamer	NULL
site	NULL
from	NULL
an	NULL
Igx	NULL
promoter	NULL
(	NULL
38	NULL
)	NULL
by	NULL
DNase	NULL
I	NULL
protection	NULL
analysis	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
Oct-1	NULL
binding	NULL
to	NULL
the	NULL
DNA	NULL
probe	NULL
used	NULL
for	NULL
DNase	NULL
I	NULL
protection	NULL
analysis	NULL
,	NULL
we	NULL
placed	NULL
nearby	NULL
to	NULL
the	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
octamer	NULL
site	NULL
an	NULL
octamer	NULL
site	NULL
with	NULL
a	NULL
higher	NULL
affinity	NULL
for	NULL
Oct-1	NULL
,	NULL
the	NULL
histone	NULL
H2B	NULL
promoter	NULL
octamer	NULL
site	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Figure	NULL
2	NULL
shows	NULL
Oct-1	NULL
POU	NULL
domain	NULL
binding	NULL
Oct-1-OCA¥-B	NULL
COREGULATORY	NULL
FUNCTION	NULL
-	NULL
7297	NULL
to	NULL
these	NULL
two	NULL
octamer	NULL
sites	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
full-length	NULL
OCA-B	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
OCA-B	NULL
had	NULL
no	NULL
evident	NULL
effect	NULL
on	NULL
the	NULL
DNase	NULL
I	NULL
cleavage	NULL
pattern	NULL
of	NULL
the	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

At	NULL
a	NULL
concentration	NULL
of	NULL
Oct-1	NULL
POU	NULL
domain	NULL
that	NULL
affords	NULL
full	NULL
protection	NULL
of	NULL
the	NULL
histone	NULL
H2B	NULL
octamer	NULL
site	NULL
but	NULL
only	NULL
partial	NULL
protection	NULL
of	NULL
the	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
OCA-B	NULL
enhanced	NULL
but	NULL
otherwise	NULL
did	NULL
not	NULL
change	NULL
Oct-1	NULL
POU	NULL
domain	NULL
protection	NULL
of	NULL
the	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
site	NULL
(	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

The	NULL
enhanced	NULL
protection	NULL
was	NULL
dependent	NULL
on	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
because	NULL
it	NULL
was	NULL
not	NULL
observed	NULL
when	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
POUg	NULL
pz	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
the	NULL
octamer	NULL
site	NULL
(	NULL
A	NULL
;	NULL
-T	NULL
)	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
contained	NULL
single	NULL
point	NULL
mutations	NULL
that	NULL
had	NULL
(	NULL
see	NULL
below	NULL
)	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
Oct-1	NULL
binding	NULL
alone	NULL
but	NULL
specifically	NULL
disrupted	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
is	NULL
the	NULL
case	NULL
with	NULL
VP16	NULL
on	NULL
a	NULL
TAATGARAT	NULL
element	NULL
(	NULL
5	NULL
)	NULL
,	NULL
OCA-B	NULL
can	NULL
stabilize	NULL
Oct-1	NULL
on	NULL
an	NULL
octamer	NULL
site	NULL
in	NULL
vitro	NULL
.	NULL

To	NULL
measure	NULL
OCA-B	NULL
recruitment	NULL
of	NULL
Oct-1	NULL
to	NULL
an	NULL
OCA-B-responsive	NULL
element	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
fused	NULL
the	NULL
potent	NULL
mRNA	NULL
promoter	NULL
activation	NULL
domain	NULL
of	NULL
VP16	NULL
to	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
and	NULL
assayed	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
fusion	NULL
protein	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
OCA-B	NULL
in	NULL
a	NULL
transient-expression	NULL
assay	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
this	NULL
fusion	NULL
protein	NULL
should	NULL
reflect	NULL
its	NULL
relative	NULL
occupancy	NULL
of	NULL
the	NULL
octamer	NULL
response	NULL
element	NULL
.	NULL

For	NULL
this	NULL
assay	NULL
,	NULL
we	NULL
created	NULL
a	NULL
reporter	NULL
containing	NULL
two	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
octamer	NULL
site	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
-globin	NULL
promoter	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
any	NULL
transcriptional	NULL
readout	NULL
reflected	NULL
recruitment	NULL
of	NULL
the	NULL
Oct-1-VP16	NULL
fusion	NULL
protein	NULL
rather	NULL
than	NULL
direct	NULL
activation	NULL
by	NULL
OCA-B	NULL
,	NULL
we	NULL
removed	NULL
the	NULL
carboxy-terminal	NULL
activation	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
120	NULL
to	NULL
256	NULL
)	NULL
from	NULL
OCA-B	NULL
;	NULL
the	NULL
remainder	NULL
of	NULL
OCA-B	NULL
(	NULL
OCA-BAC	NULL
)	NULL
retains	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
16	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
such	NULL
an	NULL
in	NULL
vivo	NULL
Oct-1	NULL
recruitment	NULL
assay	NULL
.	NULL

When	NULL
OCA-BAC	NULL
was	NULL
transiently	NULL
expressed	NULL
either	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
there	NULL
was	NULL
no	NULL
evident	NULL
activation	NULL
of	NULL
transcription	NULL
,	NULL
as	NULL
expected	NULL
.	NULL

To	NULL
our	NULL
surprise	NULL
,	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-VP16	NULL
fusion	NULL
protein	NULL
alone	NULL
did	NULL
not	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
octamer	NULL
site	NULL
effectively	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
;	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
OCA-BAC	NULL
,	NULL
however	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
transcription	NULL
were	NULL
achieved	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
enhanced	NULL
activation	NULL
of	NULL
the	NULL
reporter	NULL
by	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-VP16	NULL
fusion	NULL
protein	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
OCA-BAC	NULL
likely	NULL
results	NULL
from	NULL
its	NULL
recruitment	NULL
to	NULL
the	NULL
octamer	NULL
site	NULL
because	NULL
(	NULL
i	NULL
)	NULL
immunoblot	NULL
analysis	NULL
showed	NULL
that	NULL
its	NULL
expression	NULL
was	NULL
not	NULL
elevated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
OCA-BAC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
OCA-BAC	NULL
enhancement	NULL
of	NULL
transcription	NULL
was	NULL
disrupted	NULL
by	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
and	NULL
octamer	NULL
site	NULL
lane	NULL
14	NULL
)	NULL
point	NULL
mutations	NULL
introduced	NULL
above	NULL
.	NULL

Indeed	NULL
,	NULL
when	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
and	NULL
octamer	NULL
site	NULL
(	NULL
A	NULL
;	NULL
-T	NULL
)	NULL
point	NULL
mutations	NULL
were	NULL
combined	NULL
,	NULL
OCA-BAC	NULL
had	NULL
no	NULL
evident	NULL
effect	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-VP16	NULL
fusion	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
;	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
16	NULL
)	NULL
.	NULL

These	NULL
results	NULL
can	NULL
be	NULL
explained	NULL
by	NULL
OCA-B	NULL
recruitment	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
fusion	NULL
protein	NULL
to	NULL
the	NULL
octamer	NULL
site	NULL
in	NULL
vivo	NULL
or	NULL
by	NULL
OCA-B	NULL
enhancement	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
VP16	NULL
transcriptional	NULL
activation	NULL
domain	NULL
tethered	NULL
to	NULL
DNA	NULL
by	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
;	NULL
although	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
latter	NULL
,	NULL
we	NULL
favor	NULL
the	NULL
former	NULL
hypothesis	NULL
because	NULL
it	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
studies	NULL
described	NULL
above	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
as	NULL
is	NULL
the	NULL
case	NULL
with	NULL
VP16	NULL
on	NULL
a	NULL
TAATGARAT	NULL
element	NULL
(	NULL
5	NULL
)	NULL
,	NULL
OCA-B	NULL
association	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
results	NULL
in	NULL
Oct-1	NULL
recruitment	NULL
to	NULL
DNA	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
our	NULL
surprise	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
OCA-B	NULL
,	NULL
these	NULL
effects	NULL
were	NULL
seen	NULL
even	NULL
with	NULL
a	NULL
consensus	NULL
octamer	NULL
site	NULL
.	NULL

Together	NULL
,	NULL
the	NULL
characterization	NULL
of	NULL
the	NULL
OCA-B	NULL
activation	NULL
domain	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
OCA-B	NULL
on	NULL
Oct-1	NULL
binding	NULL
to	NULL
an	NULL
octamer	NULL
7298	NULL
BABB	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

©	NULL
3	NULL
o	NULL
00	NULL
CE	NULL
s	NULL
5.03	NULL
5	NULL
iw	NULL
Phe	NULL
A	NULL
a	NULL
3	NULL
3	NULL
8	NULL
g	NULL
3	NULL
)	NULL
a	NULL
”	NULL
?	NULL

Effector	NULL
:	NULL
-	NULL
8	NULL
8	NULL
&	NULL
.	NULL

-	NULL
8	NULL
8	NULL
8	NULL
I	NULL
T	NULL
U	NULL
U	NULL
1	NULL
T	NULL
I	NULL
T	NULL
U	NULL
1	NULL
OCA-BAC	NULL
:	NULL
-	NULL
4+	NULL
-	NULL
4	NULL
&	NULL
0	NULL
-	NULL
+0	NULL
-	NULL
+	NULL
-o	NULL
$	NULL
00	NULL
-	NULL
$	NULL
o	NULL
#	NULL
0	NULL
o-	NULL
+	NULL
tumne	NULL
B	NULL
WT	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
evel	NULL
mour	NULL
wg	NULL
#	NULL
®	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
I	NULL
-	NULL
1	NULL
1	NULL
As	NULL
>	NULL
T	NULL
Igx	NULL
OCTAMER	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

OCA-B	NULL
recruits	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
to	NULL
the	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
octamer	NULL
site	NULL
in	NULL
vivo	NULL
.	NULL

Transcriptional	NULL
activation	NULL
was	NULL
measured	NULL
by	NULL
RNase	NULL
protection	NULL
analysis	NULL
of	NULL
RNA	NULL
isolated	NULL
from	NULL
transiently	NULL
transfected	NULL
HeLa	NULL
cells	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Wild-type	NULL
(	NULL
WT	NULL
;	NULL
lanes	NULL
1	NULL
through	NULL
8	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
A5-T	NULL
;	NULL
lanes	NULL
9	NULL
through	NULL
16	NULL
)	NULL
Ig	NULL
(	NULL
x	NULL
)	NULL
octamer-containing	NULL
reporter	NULL
plasmids	NULL
were	NULL
cotransfected	NULL
with	NULL
(	NULL
+	NULL
;	NULL
even-numbered	NULL
lanes	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
;	NULL
odd-numbered	NULL
lanes	NULL
)	NULL
an	NULL
OCA-BAC	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
through	NULL
119	NULL
)	NULL
expression	NULL
vector	NULL
and	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
expression	NULL
vector	NULL
indicated	NULL
above	NULL
each	NULL
pair	NULL
of	NULL
lanes	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
correctly	NULL
initiated	NULL
«	NULL
-globin	NULL
(	NULL
«	NULL
)	NULL
and	NULL
B-globin	NULL
(	NULL
B	NULL
)	NULL
transcripts	NULL
are	NULL
indicated	NULL
.	NULL

site	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
reveal	NULL
that	NULL
OCA-B	NULL
is	NULL
a	NULL
functional	NULL
analog	NULL
of	NULL
VP16	NULL
;	NULL
it	NULL
alters	NULL
both	NULL
the	NULL
transcriptional	NULL
activation	NULL
and	NULL
DNA-binding	NULL
properties	NULL
of	NULL
Oct-1	NULL
in	NULL
a	NULL
manner	NULL
analogous	NULL
to	NULL
that	NULL
of	NULL
VP16	NULL
.	NULL

OCA-B	NULL
makes	NULL
multiple	NULL
DNA	NULL
contacts	NULL
in	NULL
the	NULL
major	NULL
groove	NULL
at	NULL
the	NULL
center	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

On	NULL
a	NULL
VP16-responsive	NULL
TAATGARAT	NULL
site	NULL
containing	NULL
an	NULL
overlapping	NULL
octamer	NULL
sequence	NULL
[	NULL
(	NULL
OCTA*	NULL
)	NULL
TAATGARAT	NULL
]	NULL
,	NULL
residues	NULL
3	NULL
'	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
are	NULL
important	NULL
for	NULL
VP16	NULL
association	NULL
with	NULL
Oct-1	NULL
(	NULL
15	NULL
,	NULL
20	NULL
,	NULL
24	NULL
,	NULL
31	NULL
,	NULL
35	NULL
)	NULL
.	NULL

OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
is	NULL
also	NULL
DNA	NULL
sequence	NULL
dependent	NULL
;	NULL
the	NULL
fifth	NULL
position	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
ATGCAAAT	NULL
is	NULL
important	NULL
for	NULL
OCA-B	NULL
binding	NULL
to	NULL
Oct-1	NULL
(	NULL
4	NULL
,	NULL
16	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
DNA	NULL
sequence	NULL
requirements	NULL
for	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
in	NULL
greater	NULL
detail	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
individual	NULL
substitutions	NULL
of	NULL
the	NULL
central	NULL
four	NULL
residues	NULL
of	NULL
a	NULL
perfect	NULL
octamer	NULL
site	NULL
(	NULL
positions	NULL
3	NULL
through	NULL
6	NULL
[	NULL
ATGCAAAT	NULL
]	NULL
)	NULL
with	NULL
thymine	NULL
on	NULL
OCA-B-Oct-1	NULL
complex	NULL
formation	NULL
in	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
retardation	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
site	NULL
complex	NULL
was	NULL
determined	NULL
on	NULL
the	NULL
histone	NULL
H2B	NULL
octamer	NULL
site	NULL
(	NULL
23	NULL
)	NULL
,	NULL
we	NULL
used	NULL
this	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
to	NULL
study	NULL
OCA-B	NULL
association	NULL
with	NULL
DNA-bound	NULL
Oct-1	NULL
.	NULL

All	NULL
of	NULL
the	NULL
thymine	NULL
substitutions	NULL
in	NULL
the	NULL
core	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
affected	NULL
Oct-1	NULL
binding	NULL
but	NULL
to	NULL
various	NULL
degrees	NULL
(	NULL
see	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
thymine	NULL
substitutions	NULL
on	NULL
OCA-B	NULL
binding	NULL
,	NULL
we	NULL
titrated	NULL
the	NULL
concentration	NULL
of	NULL
Oct-1	NULL
to	NULL
generate	NULL
similar	NULL
levels	NULL
of	NULL
octamer	NULL
site	NULL
binding	NULL
to	NULL
all	NULL
of	NULL
the	NULL
thymine-substituted	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
5	NULL
;	NULL
only	NULL
the	NULL
Oct-l-octamer	NULL
site	NULL
complex	NULL
is	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
in	NULL
vitro-translated	NULL
OCA-B	NULL
to	NULL
these	NULL
binding	NULL
reactions	NULL
retarded	NULL
the	NULL
mobility	NULL
of	NULL
Oct-1	NULL
on	NULL
the	NULL
wild-type	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
;	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
7	NULL
with	NULL
lanes	NULL
8	NULL
and	NULL
14	NULL
)	NULL
.	NULL

OCA-B	NULL
,	NULL
however	NULL
,	NULL
failed	NULL
to	NULL
associate	NULL
with	NULL
Oct-1	NULL
on	NULL
the	NULL
two	NULL
sites	NULL
carrying	NULL
thymine	NULL
substitutions	NULL
at	NULL
positions	NULL
5	NULL
and	NULL
6	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
;	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
,	NULL
respectively	NULL
)	NULL
and	NULL
had	NULL
intermediate	NULL
effects	NULL
on	NULL
the	NULL
mobilities	NULL
of	NULL
Oct-1	NULL
complexes	NULL
on	NULL
the	NULL
two	NULL
sites	NULL
with	NULL
substitutions	NULL
at	NULL
positions	NULL
3	NULL
and	NULL
4	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
the	NULL
intermedi-	NULL
ate	NULL
effects	NULL
of	NULL
the	NULL
substitutions	NULL
at	NULL
positions	NULL
3	NULL
and	NULL
4	NULL
is	NULL
not	NULL
known	NULL
but	NULL
may	NULL
reflect	NULL
partial	NULL
interference	NULL
with	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
.	NULL

Together	NULL
,	NULL
the	NULL
results	NULL
with	NULL
these	NULL
thymine	NULL
substitutions	NULL
indicate	NULL
that	NULL
OCA-B	NULL
interacts	NULL
directly	NULL
or	NULL
indirectly	NULL
with	NULL
the	NULL
four	NULL
central	NULL
residues	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

In	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
site	NULL
cocrystal	NULL
structure	NULL
,	NULL
the	NULL
major	NULL
groove	NULL
of	NULL
the	NULL
DNA	NULL
is	NULL
accessible	NULL
at	NULL
positions	NULL
5	NULL
and	NULL
6	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
(	NULL
ATGCAAAT	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
strong	NULL
effects	NULL
of	NULL
the	NULL
thymine	NULL
substitutions	NULL
at	NULL
positions	NULL
5	NULL
and	NULL
6	NULL
on	NULL
OCA-B	NULL
association	NULL
with	NULL
the	NULL
Oct-1-DNA	NULL
complex	NULL
reflected	NULL
interaction	NULL
with	NULL
the	NULL
major	NULL
groove	NULL
of	NULL
DNA	NULL
,	NULL
we	NULL
individually	NULL
replaced	NULL
these	NULL
two	NULL
AT	NULL
base	NULL
pairs	NULL
with	NULL
IC	NULL
base	NULL
pairs	NULL
,	NULL
substitutions	NULL
that	NULL
selectively	NULL
alter	NULL
the	NULL
major	NULL
groove	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Although	NULL
they	NULL
permitted	NULL
binding	NULL
by	NULL
Oct-1	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
both	NULL
of	NULL
these	NULL
IC	NULL
substitutions	NULL
interfered	NULL
with	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
severely	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
OCA-B	NULL
indeed	NULL
recognizes	NULL
the	NULL
major	NULL
groove	NULL
of	NULL
DNA	NULL
at	NULL
these	NULL
two	NULL
positions	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
substitution	NULL
at	NULL
position	NULL
5	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
parallel	NULL
disruption	NULL
of	NULL
OCA-B	NULL
binding	NULL
by	NULL
a	NULL
5-methyl	NULL
IC	NULL
base	NULL
pair	NULL
at	NULL
this	NULL
position	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
other	NULL
substitutions	NULL
we	NULL
analyzed	NULL
,	NULL
the	NULL
IC	NULL
substitution	NULL
at	NULL
position	NULL
6	NULL
did	NULL
not	NULL
affect	NULL
Oct-1	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
site	NULL
(	NULL
see	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
at	NULL
least	NULL
at	NULL
this	NULL
position	NULL
OCA-B	NULL
interacts	NULL
directly	NULL
with	NULL
the	NULL
major	NULL
groove	NULL
of	NULL
DNA	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
as	NULL
is	NULL
the	NULL
case	NULL
with	NULL
VP16	NULL
,	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
depends	NULL
on	NULL
multiple	NULL
DNA	NULL
residues	NULL
in	NULL
the	NULL
regulatory	NULL
site	NULL
;	NULL
however	NULL
,	NULL
unlike	NULL
VP16	NULL
,	NULL
which	NULL
depends	NULL
on	NULL
residues	NULL
3	NULL
'	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
,	NULL
OCA-B	NULL
depends	NULL
on	NULL
residues	NULL
within	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

OCA-B	NULL
fails	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
Pit-1	NULL
POU	NULL
domain	NULL
due	NULL
to	NULL
amino	NULL
acid	NULL
differences	NULL
in	NULL
both	NULL
the	NULL
POU	NULL
and	NULL
POU	NULL
,	NULL
domains	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
VP16	NULL
(	NULL
24	NULL
,	NULL
47	NULL
)	NULL
,	NULL
OCA-B	NULL
does	NULL
not	NULL
discriminate	NULL
between	NULL
the	NULL
POU	NULL
domains	NULL
of	NULL
Oct-1	NULL
and	NULL
the	NULL
closely	NULL
related	NULL
B-cell	NULL
POU	NULL
domain	NULL
protein	NULL
Oct-2	NULL
(	NULL
4	NULL
,	NULL
17	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
.	NULL

The	NULL
more	NULL
distantly	NULL
related	NULL
N-Oct-3	NULL
(	NULL
Brn-2	NULL
)	NULL
,	NULL
Oct-3/4	NULL
,	NULL
and	NULL
Oct-6	NULL
(	NULL
SCIP	NULL
)	NULL
POU	NULL
domains	NULL
,	NULL
however	NULL
,	NULL
fail	NULL
to	NULL
interact	NULL
with	NULL
OCA-B	NULL
(	NULL
17	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
studied	NULL
OCA-B	NULL
interaction	NULL
with	NULL
the	NULL
pituitary	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
A.	NULL
OCTAMER	NULL
wT	NULL
T	NULL
T	NULL
A	NULL
T	NULL
G	NULL
C	NULL
A	NULL
A	NULL
A	NULL
T	NULL
A	NULL
A	NULL
T	NULL
ii	NULL
C4	NULL
>	NULL
T	NULL
F	NULL
Ag	NULL
>	NULL
T	NULL
T	NULL
Ag	NULL
>	NULL
T	NULL
T	NULL
B	NULL
.	NULL

-	NULL
OCA-B	NULL
+	NULL
OCA-B	NULL
rr—r—v—l-	NULL
||	NULL
-o-	NULL
-o-	NULL
|	NULL
Atta	NULL
ILI	NULL
11s	NULL
EFa	NULL
ak	NULL
s	NULL
&	NULL
s	NULL
ea	NULL
ik	NULL
-s	NULL
Oct-1/	NULL
..	NULL
oca-B	NULL
o-	NULL
©	NULL
@	NULL
eame	NULL
O	NULL
*	NULL
g	NULL
#	NULL
160A	NULL
1	NULL
2	NULL
B	NULL
4	NULL
506	NULL
70	NULL
8	NULL
9	NULL
10	NULL
41	NULL
12	NULL
13	NULL
14	NULL
C.	NULL
-	NULL
OCA-B	NULL
+	NULL
OCA-B	NULL
1	NULL
lB	NULL
'—	NULL
5583.5	NULL
5808s	NULL
5	NULL
leu	NULL
'	NULL
_	NULL
Oct-1/	NULL
OCA-B	NULL
-	NULL
Oct-1	NULL
Oct-1	NULL
-	NULL
..-	NULL
#	NULL
»	NULL
o	NULL
@	NULL
6	NULL
7	NULL
)	NULL
8	NULL
)	NULL
2	NULL
,	NULL
19	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Changes	NULL
in	NULL
the	NULL
major	NULL
groove	NULL
of	NULL
the	NULL
octamer	NULL
site	NULL
disrupt	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
and	NULL
DNA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Wild-type	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
mutant	NULL
H2B	NULL
octamer	NULL
sites	NULL
.	NULL

Each	NULL
mutation	NULL
is	NULL
numbered	NULL
according	NULL
to	NULL
its	NULL
position	NULL
within	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
retardation	NULL
analysis	NULL
of	NULL
Oct-1	NULL
bound	NULL
to	NULL
the	NULL
octamer	NULL
sites	NULL
indicated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
;	NULL
lanes	NULL
1	NULL
through	NULL
7	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
;	NULL
lanes	NULL
8	NULL
through	NULL
14	NULL
)	NULL
of	NULL
OCA-B	NULL
.	NULL

MUT	NULL
,	NULL
a	NULL
double-base	NULL
pair	NULL
substitution	NULL
at	NULL
the	NULL
first	NULL
and	NULL
second	NULL
positions	NULL
of	NULL
the	NULL
octamer	NULL
site	NULL
described	NULL
previously	NULL
(	NULL
H2B/OCT	NULL
AdpmJ	NULL
[	NULL
6	NULL
]	NULL
)	NULL
.	NULL

To	NULL
obtain	NULL
equal	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
to	NULL
G	NULL
;	NULL
-T	NULL
,	NULL
C	NULL
,	NULL
-	NULL
>	NULL
T	NULL
,	NULL
Ag-T	NULL
,	NULL
and	NULL
A	NULL
,	NULL
-T	NULL
sites	NULL
,	NULL
more	NULL
Oct-1	NULL
protein	NULL
(	NULL
4-	NULL
,	NULL
1.6-	NULL
,	NULL
1.6-	NULL
,	NULL
and	NULL
16-fold	NULL
,	NULL
respectively	NULL
)	NULL
compared	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
WT	NULL
site	NULL
sample	NULL
was	NULL
used	NULL
.	NULL

MUT	NULL
samples	NULL
contained	NULL
the	NULL
maximum	NULL
(	NULL
16-fold	NULL
)	NULL
enrichment	NULL
of	NULL
Oct-1	NULL
protein	NULL
.	NULL

Oct-1	NULL
,	NULL
Oct-1-DNA	NULL
complex	NULL
;	NULL
Oct-1/OCA-B	NULL
,	NULL
Oct-1-OCA-B-DNA	NULL
complexes	NULL
.	NULL

Free	NULL
DNA	NULL
is	NULL
not	NULL
shown	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
retardation	NULL
analysis	NULL
of	NULL
Oct-1	NULL
to	NULL
IC	NULL
substitutions	NULL
at	NULL
positions	NULL
5	NULL
and	NULL
6	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
;	NULL
lanes	NULL
1	NULL
through	NULL
5	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
;	NULL
lanes	NULL
6	NULL
through	NULL
10	NULL
)	NULL
of	NULL
OCA-B	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
each	NULL
probe	NULL
is	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

To	NULL
obtain	NULL
equal	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
IC	NULL
,	NULL
site	NULL
,	NULL
fourfold	NULL
more	NULL
Oct-1	NULL
protein	NULL
compared	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
WT	NULL
site	NULL
sample	NULL
was	NULL
used	NULL
.	NULL

The	NULL
IC	NULL
,	NULL
sample	NULL
contained	NULL
the	NULL
same	NULL
level	NULL
of	NULL
Oct-1	NULL
as	NULL
did	NULL
the	NULL
WT	NULL
site	NULL
sample	NULL
,	NULL
and	NULL
MUT	NULL
samples	NULL
contained	NULL
16-fold	NULL
more	NULL
protein	NULL
.	NULL

Oct-1	NULL
,	NULL
Oct-1-DNA	NULL
complex	NULL
;	NULL
Oct-1/OCA-B	NULL
,	NULL
Oct-1-OCA-B-DNA	NULL
complex	NULL
.	NULL

Free	NULL
DNA	NULL
is	NULL
not	NULL
shown	NULL
.	NULL

POU	NULL
domain	NULL
protein	NULL
Pit-1	NULL
(	NULL
3	NULL
,	NULL
21	NULL
)	NULL
,	NULL
which	NULL
is	NULL
about	NULL
50	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

Figure	NULL
5	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
retardation	NULL
assay	NULL
of	NULL
OCA-B	NULL
interaction	NULL
with	NULL
in	NULL
vitro-translated	NULL
Oct-1	NULL
,	NULL
Pit-1	NULL
,	NULL
and	NULL
Oct-1-Pit-1	NULL
POU	NULL
domain	NULL
chimeras	NULL
.	NULL

All	NULL
of	NULL
the	NULL
POU	NULL
domains	NULL
assayed	NULL
bound	NULL
the	NULL
histone	NULL
H2B	NULL
octamer	NULL
site	NULL
effectively	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
6	NULL
)	NULL
;	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
however	NULL
,	NULL
the	NULL
Pit-1	NULL
POU	NULL
domain	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
OCA-B	NULL
(	NULL
compare	NULL
lanes	NULL
8	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Determinants	NULL
in	NULL
the	NULL
Pit-1	NULL
POU	NULL
and	NULL
POUy	NULL
domains	NULL
are	NULL
responsible	NULL
for	NULL
preventing	NULL
OCA-B	NULL
association	NULL
with	NULL
this	NULL
POU	NULL
domain	NULL
,	NULL
because	NULL
when	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
,	NULL
linker	NULL
,	NULL
and	NULL
POU	NULL
;	NULL
;	NULL
domain	NULL
were	NULL
individually	NULL
replaced	NULL
with	NULL
the	NULL
corresponding	NULL
region	NULL
from	NULL
Pit-1	NULL
,	NULL
only	NULL
the	NULL
linker	NULL
swap	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
associate	NULL
with	NULL
OCA-B	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
9	NULL
through	NULL
11	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
OCA-B	NULL
recognizes	NULL
the	NULL
Oct-1	NULL
POU	NULL
and	NULL
POU	NULL
Oct-1-OCA¥-B	NULL
COREGULATORY	NULL
FUNCTION	NULL
-	NULL
7299	NULL
$	NULL
8	NULL
3	NULL
8	NULL
€	NULL
8	NULL
a	NULL
.	NULL

-	NULL
a	NULL
.	NULL

[	NULL
-AT-	NULL
TOI	NULL
]	NULL
CIT	NULL
Ost	NULL
opposes	NULL
)	NULL
rid	NULL
-	NULL
OCA-B	NULL
+	NULL
OCA-B	NULL
T	NULL
Toor	NULL
1	NULL
POUp	NULL
POU-domain	NULL
Linker	NULL
chimeras	NULL
:	NULL
~	NULL
POUs	NULL
OcaA-B/POU	NULL
-	NULL
86	NULL
&	NULL
rou-	NULL
_	NULL
COee®se	NULL
*	NULL
0	NULL
-	NULL
8	NULL
a	NULL
``	NULL
-r	NULL
--	NULL
CPOCACACO®	NULL
boO	NULL
@	NULL
0®	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
OCTAMER	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

OCA-B	NULL
distinguishes	NULL
between	NULL
both	NULL
the	NULL
Oct-1	NULL
and	NULL
Pit-1	NULL
POU	NULL
and	NULL
POU	NULL
,	NULL
domains	NULL
.	NULL

An	NULL
electrophoretic	NULL
mobility	NULL
retardation	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
histone	NULL
H2B	NULL
octamer	NULL
probe	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
each	NULL
Oct-1-Pit-1	NULL
chimeric	NULL
protein	NULL
assayed	NULL
is	NULL
indicated	NULL
above	NULL
the	NULL
corresponding	NULL
lane	NULL
.	NULL

White	NULL
boxes	NULL
represent	NULL
segments	NULL
derived	NULL
from	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
and	NULL
gray	NULL
boxes	NULL
represent	NULL
segments	NULL
derived	NULL
from	NULL
the	NULL
Pit-1	NULL
POU	NULL
domain	NULL
.	NULL

Wild-type	NULL
and	NULL
chimeric	NULL
POU	NULL
domains	NULL
were	NULL
produced	NULL
in	NULL
vitro	NULL
and	NULL
assayed	NULL
in	NULL
either	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
;	NULL
lanes	NULL
1	NULL
through	NULL
6	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
;	NULL
lanes	NULL
7	NULL
through	NULL
12	NULL
)	NULL
of	NULL
in	NULL
vitro-translated	NULL
OCA-B	NULL
.	NULL

POU	NULL
,	NULL
POU	NULL
domain-DNA-containing	NULL
complexes	NULL
;	NULL
OCA-B/POU	NULL
,	NULL
POU	NULL
domain-OCA-B-DNA-containing	NULL
complexes	NULL
.	NULL

domains	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
VP16	NULL
recognizes	NULL
only	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
41	NULL
,	NULL
47	NULL
)	NULL
.	NULL

OCA-B	NULL
and	NULL
SNAP	NULL
,	NULL
interactions	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
overlap	NULL
.	NULL

To	NULL
probe	NULL
the	NULL
determinants	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
interaction	NULL
in	NULL
more	NULL
detail	NULL
,	NULL
we	NULL
analyzed	NULL
OCA-B	NULL
association	NULL
with	NULL
an	NULL
extended	NULL
series	NULL
of	NULL
Oct-1	NULL
POU	NULL
domains	NULL
carrying	NULL
one	NULL
to	NULL
six	NULL
amino	NULL
acid	NULL
substitutions	NULL
from	NULL
the	NULL
Pit-1	NULL
POU	NULL
,	NULL
domain	NULL
sequence	NULL
across	NULL
the	NULL
entire	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
analysis	NULL
revealed	NULL
that	NULL
Pit-1	NULL
sequences	NULL
in	NULL
two	NULL
regions	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
,	NULL
in	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
«	NULL
-helix	NULL
1	NULL
(	NULL
EIR-1	NULL
)	NULL
and	NULL
within	NULL
«	NULL
-helix	NULL
4	NULL
(	NULL
Pa4	NULL
)	NULL
,	NULL
disrupted	NULL
OCA-B	NULL
association	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
EIR-1	NULL
substitution	NULL
also	NULL
affects	NULL
Oct-1	NULL
POU	NULL
domain	NULL
association	NULL
with	NULL
the	NULL
basal	NULL
snRNA	NULL
promoter	NULL
complex	NULL
SNAP	NULL
/	NULL
PTF	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
that	NULL
case	NULL
,	NULL
of	NULL
three	NULL
substitutions	NULL
in	NULL
EIR-1	NULL
(	NULL
DSE	NULL
,	NULL
L6I	NULL
,	NULL
and	NULL
E7R	NULL
)	NULL
,	NULL
only	NULL
one	NULL
(	NULL
E7R	NULL
)	NULL
affects	NULL
Oct-1	NULL
POU	NULL
domain	NULL
interaction	NULL
with	NULL
SNAP	NULL
,	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
effect	NULL
on	NULL
SNAP	NULL
,	NULL
interaction	NULL
,	NULL
only	NULL
the	NULL
E7R	NULL
swap	NULL
in	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
«	NULL
-helix	NULL
1	NULL
affected	NULL
OCA-B	NULL
association	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
SNAP	NULL
,	NULL
(	NULL
32	NULL
)	NULL
and	NULL
consistent	NULL
with	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
Pa4	NULL
substitution	NULL
,	NULL
the	NULL
complementary	NULL
R7E	NULL
substitution	NULL
in	NULL
the	NULL
Pit-1	NULL
POU	NULL
,	NULL
domain	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
the	NULL
Pit-1	NULL
POU	NULL
domain	NULL
for	NULL
association	NULL
with	NULL
OCA-B	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
OCA-B	NULL
,	NULL
a	NULL
B-cell	NULL
Oct-1	NULL
coregulator	NULL
,	NULL
and	NULL
SNAP	NULL
,	NULL
,	NULL
,	NULL
a	NULL
basal	NULL
snRNA	NULL
promoter	NULL
complex	NULL
,	NULL
recognize	NULL
the	NULL
same	NULL
precise	NULL
difference	NULL
within	NULL
the	NULL
amino-termi-	NULL
7300	NULL
BABB	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Interaction	NULL
al	NULL
|	NULL
|_	NULL
a2	NULL
[	NULL
eas	NULL
|	NULL
|	NULL
od	NULL
|	NULL
with	NULL
cca-s	NULL
Oct-1	NULL
_	NULL
WT	NULL
EEPSDLEELEQFAKTFKQRRIKLGFTQGDVGLAMCGKLYGNDFSQTTI	NULL
SRFEALNL	NULL
SFKNMCKLKPLLEKWLNDAE	NULL
+	NULL
Pit-1	NULL
_	NULL
WTP	NULL
MDSPEIR	NULL
...	NULL
...	NULL
NE	NULL
.	NULL

.V	NULL
...	NULL
...	NULL
Y..TN..E.LAAVH	NULL
.	NULL

SE	NULL
...	NULL
...	NULL
C	NULL
...	NULL
N.Q	NULL
...	NULL
..	NULL
A	NULL
...	NULL
.AI.S	NULL
...	NULL
EE..	NULL
EIR-1	NULL
EIR	NULL
.	NULL

...	NULL
..	NULL
kee	NULL
aa	NULL
eae	NULL
e	NULL
a	NULL
n	NULL
en	NULL
d	NULL
a	NULL
n	NULL
e	NULL
nb	NULL
a	NULL
n	NULL
n	NULL
n	NULL
e	NULL
a	NULL
n	NULL
n	NULL
rn	NULL
a	NULL
n	NULL
n	NULL
ae	NULL
ea	NULL
na	NULL
nn	NULL
an	NULL
e	NULL
an	NULL
n	NULL
ae	NULL
e	NULL
nn	NULL
e	NULL
e	NULL
n	NULL
k	NULL
e	NULL
e	NULL
a	NULL
e	NULL
ees	NULL
NEV-1	NULL
==	NULL
...	NULL
l	NULL
...	NULL
...	NULL
e.	NULL
NE	NULL
.	NULL

.	NULL

V..	NULL
u	NULL
aul	NULL
aaa	NULL
a	NULL
k	NULL
a	NULL
k	NULL
a	NULL
a	NULL
k	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
a	NULL
e	NULL
a	NULL
a	NULL
n	NULL
a	NULL
e	NULL
a	NULL
e	NULL
e	NULL
ae	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
ea	NULL
a	NULL
e	NULL
a	NULL
a	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
ee	NULL
+	NULL
TNE-2	NULL
=	NULL
...	NULL
l	NULL
...	NULL
...	NULL
er	NULL
.	NULL

rre	NULL
kkk	NULL
...	NULL
..	NULL
TN	NULL
.	NULL

.	NULL

Buu	NULL
uuu	NULL
aaa	NULL
aaa	NULL
e	NULL
a	NULL
a	NULL
k	NULL
a	NULL
e	NULL
k	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
a	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
a	NULL
a	NULL
e	NULL
e	NULL
e	NULL
e	NULL
a	NULL
ee	NULL
eas	NULL
+	NULL
o	NULL
ee	NULL
AAVH.SE	NULL
.	NULL

...	NULL
...	NULL
...	NULL
e.	NULL
e	NULL
ee	NULL
e	NULL
eee	NULL
ek	NULL
keke	NULL
ees	NULL
+	NULL
Oct-1	NULL
|	NULL
S48C/ASBN	NULL
reer	NULL
ka	NULL
ters	NULL
e	NULL
k	NULL
erea	NULL
e	NULL
ee	NULL
ren	NULL
ae	NULL
ees	NULL
ae	NULL
ae	NULL
+	NULL
POA	NULL
L	NULL
uuu	NULL
ae	NULL
k	NULL
e	NULL
a	NULL
a	NULL
e	NULL
a	NULL
a	NULL
e	NULL
a	NULL
a	NULL
k	NULL
a	NULL
e	NULL
a	NULL
e	NULL
k	NULL
ae	NULL
a	NULL
a	NULL
k	NULL
ae	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
a	NULL
ee	NULL
a	NULL
eee	NULL
ees	NULL
A	NULL
AlI.S	NULL
...	NULL
EE	NULL
DSE	NULL
vel	NULL
e	NULL
Biv	NULL
un	NULL
a	NULL
n	NULL
a	NULL
ea	NULL
a	NULL
k	NULL
a	NULL
a	NULL
a	NULL
a	NULL
a	NULL
k	NULL
a	NULL
n	NULL
e	NULL
a	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
ae	NULL
e	NULL
a	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
a	NULL
a	NULL
e	NULL
a	NULL
a	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
ae	NULL
a	NULL
eee	NULL
+	NULL
LGI	NULL
000	NULL
lll	NULL
.	NULL

Tu	NULL
uu	NULL
e	NULL
e	NULL
e	NULL
a	NULL
a	NULL
e	NULL
a	NULL
a	NULL
k	NULL
a	NULL
e	NULL
k	NULL
a	NULL
e	NULL
e	NULL
n	NULL
e	NULL
a	NULL
e	NULL
e	NULL
e	NULL
e	NULL
ae	NULL
e	NULL
n	NULL
e	NULL
ae	NULL
e	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
ae	NULL
a	NULL
a	NULL
e	NULL
a	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
ea	NULL
eke	NULL
+	NULL
EVR	NULL
0	NULL
000	NULL
...	NULL
ll	NULL
.	NULL

Rusa	NULL
an	NULL
e	NULL
ee	NULL
k	NULL
e	NULL
ae	NULL
e	NULL
an	NULL
e	NULL
e	NULL
a	NULL
n	NULL
a	NULL
n	NULL
e	NULL
a	NULL
e	NULL
e	NULL
e	NULL
a	NULL
e	NULL
a	NULL
a	NULL
e	NULL
e	NULL
e	NULL
e	NULL
a	NULL
n	NULL
e	NULL
ae	NULL
e	NULL
n	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
e	NULL
e	NULL
a	NULL
k	NULL
ae	NULL
a	NULL
ee	NULL
ea	NULL
Pit-1	NULL
[	NULL
WT	NULL
MDSPEIRELEQFANEFKVRRIKLGYTQTNVGEALAAVHGSEF	NULL
SQTTICRFENLQLSFKNACKLKAILSKWLEEAE	NULL
~~	NULL
_	NULL
|LR7E	NULL
o	NULL
C	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

OCA-B	NULL
recognizes	NULL
multiple	NULL
amino	NULL
acid	NULL
differences	NULL
between	NULL
the	NULL
Pit-1	NULL
and	NULL
Oct-1	NULL
POUs	NULL
domains	NULL
.	NULL

The	NULL
top	NULL
line	NULL
shows	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
Oct-1	NULL
POU	NULL
;	NULL
domain	NULL
;	NULL
the	NULL
next	NULL
line	NULL
shows	NULL
the	NULL
WT	NULL
Pit-1	NULL
POUs	NULL
domain	NULL
sequence	NULL
,	NULL
with	NULL
identities	NULL
with	NULL
the	NULL
Oct-1	NULL
sequence	NULL
indicated	NULL
by	NULL
dots	NULL
.	NULL

Labeled	NULL
boxes	NULL
above	NULL
the	NULL
Oct-1	NULL
sequence	NULL
delineate	NULL
«	NULL
-helices	NULL
in	NULL
the	NULL
POUs	NULL
domain	NULL
.	NULL

The	NULL
Pit-1-derived	NULL
sequences	NULL
in	NULL
EIR-1	NULL
,	NULL
NEV-1	NULL
,	NULL
TNE-2	NULL
,	NULL
AAV-2	NULL
,	NULL
S48C/A52N	NULL
,	NULL
Pad	NULL
,	NULL
D5E	NULL
,	NULL
LGI	NULL
,	NULL
and	NULL
E7R	NULL
Oct-1	NULL
POU	NULL
domain	NULL
derivatives	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
Pit-1	NULL
POU	NULL
domain	NULL
and	NULL
the	NULL
single	NULL
Oct-1-derived	NULL
amino	NULL
acid	NULL
difference	NULL
in	NULL
the	NULL
R7E	NULL
Pit-1	NULL
POU	NULL
domain	NULL
derivative	NULL
are	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

The	NULL
ability	NULL
(	NULL
+	NULL
)	NULL
or	NULL
inability	NULL
(	NULL
-	NULL
)	NULL
of	NULL
each	NULL
WT	NULL
and	NULL
substituted	NULL
POU	NULL
domain	NULL
to	NULL
associate	NULL
with	NULL
OCA-B	NULL
,	NULL
as	NULL
assayed	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
retardation	NULL
analysis	NULL
,	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

nal	NULL
regions	NULL
of	NULL
the	NULL
Oct-1	NULL
and	NULL
Pit-1	NULL
POU	NULL
,	NULL
domains	NULL
.	NULL

However	NULL
,	NULL
OCA-B	NULL
recognized	NULL
additional	NULL
differences	NULL
in	NULL
both	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
Po4	NULL
[	NULL
Fig	NULL
.	NULL

6	NULL
]	NULL
)	NULL
and	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

OCA-B	NULL
interaction	NULL
surface	NULL
on	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

To	NULL
map	NULL
the	NULL
precise	NULL
surface	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
that	NULL
is	NULL
targeted	NULL
by	NULL
OCA-B	NULL
,	NULL
we	NULL
assayed	NULL
the	NULL
activities	NULL
of	NULL
a	NULL
systematic	NULL
series	NULL
of	NULL
alanine	NULL
substitutions	NULL
in	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

We	NULL
used	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
site	NULL
cocrystal	NULL
structure	NULL
(	NULL
23	NULL
)	NULL
to	NULL
guide	NULL
the	NULL
selection	NULL
of	NULL
residues	NULL
for	NULL
alanine	NULL
substitutions	NULL
.	NULL

An	NULL
examination	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
site	NULL
cocrystal	NULL
structure	NULL
revealed	NULL
that	NULL
the	NULL
glutamic	NULL
acid	NULL
at	NULL
position	NULL
7	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
critical	NULL
for	NULL
OCA-B	NULL
association	NULL
,	NULL
is	NULL
located	NULL
on	NULL
the	NULL
same	NULL
face	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-DNA	NULL
complex	NULL
as	NULL
are	NULL
the	NULL
DNA	NULL
major	NULL
groove	NULL
positions	NULL
that	NULL
are	NULL
important	NULL
for	NULL
interaction	NULL
with	NULL
OCA-B	NULL
(	NULL
positions	NULL
5	NULL
and	NULL
6	NULL
[	NULL
Fig	NULL
.	NULL

4	NULL
]	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
individually	NULL
replaced	NULL
all	NULL
of	NULL
the	NULL
solvent-exposed	NULL
residues	NULL
on	NULL
this	NULL
surface	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
with	NULL
alanine	NULL
.	NULL

To	NULL
test	NULL
the	NULL
importance	NULL
of	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
site	NULL
interactions	NULL
for	NULL
OCA-B	NULL
association	NULL
,	NULL
we	NULL
also	NULL
included	NULL
two	NULL
separate	NULL
alanine	NULL
substitutions	NULL
for	NULL
conserved	NULL
residues	NULL
in	NULL
the	NULL
POU	NULL
and	NULL
POU	NULL
,	NULL
domains	NULL
that	NULL
contact	NULL
DNA	NULL
(	NULL
POU	NULL
domain	NULL
residue	NULL
R49	NULL
and	NULL
POU	NULL
,	NULL
domain	NULL
residue	NULL
N51	NULL
)	NULL
.	NULL

Figure	NULL
7	NULL
summarizes	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
alanine	NULL
substitution	NULL
mutants	NULL
and	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
electrophoretic	NULL
mobility	NULL
retardation	NULL
assays	NULL
for	NULL
a	NULL
representative	NULL
set	NULL
of	NULL
mutations	NULL
.	NULL

Of	NULL
the	NULL
23	NULL
alanine	NULL
substitutions	NULL
in	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
assayed	NULL
,	NULL
only	NULL
one	NULL
(	NULL
R49A	NULL
)	NULL
had	NULL
a	NULL
great	NULL
effect	NULL
on	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
(	NULL
6	NULL
,	NULL
55	NULL
)	NULL
;	NULL
consistent	NULL
with	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
for	NULL
OCA-B	NULL
interaction	NULL
,	NULL
this	NULL
mutant	NULL
also	NULL
failed	NULL
to	NULL
associate	NULL
with	NULL
OCA-B	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Nine	NULL
of	NULL
the	NULL
other	NULL
22	NULL
POUs	NULL
alanine	NULL
substitutions	NULL
also	NULL
affected	NULL
Oct-1	NULL
POU	NULL
domain	NULL
association	NULL
with	NULL
OCA-B	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
16	NULL
)	NULL
,	NULL
mutants	NULL
L53A	NULL
,	NULL
L55SA	NULL
,	NULL
and	NULL
N59A	NULL
,	NULL
but	NULL
not	NULL
mutant	NULL
NS4A	NULL
,	NULL
failed	NULL
to	NULL
associate	NULL
effectively	NULL
with	NULL
OCA-B	NULL
.	NULL

The	NULL
representative	NULL
set	NULL
of	NULL
POU	NULL
,	NULL
domain	NULL
substitutions	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
includes	NULL
substitutions	NULL
in	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
«	NULL
-helix	NULL
1	NULL
and	NULL
in	NULL
a-helix	NULL
4	NULL
.	NULL

The	NULL
results	NULL
for	NULL
«	NULL
-helix	NULL
1	NULL
substitutions	NULL
show	NULL
that	NULL
as	NULL
was	NULL
the	NULL
case	NULL
in	NULL
Oct-1	NULL
and	NULL
Pit-1	NULL
swaps	NULL
,	NULL
E7	NULL
was	NULL
critical	NULL
for	NULL
OCA-B	NULL
association	NULL
;	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
for	NULL
the	NULL
L6I	NULL
substitution	NULL
in	NULL
Oct-1	NULL
and	NULL
Pit-1	NULL
swaps	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
the	NULL
LGA	NULL
substitution	NULL
affected	NULL
OCA-B	NULL
association	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
positions	NULL
6	NULL
and	NULL
7	NULL
are	NULL
critical	NULL
for	NULL
OCA-B	NULL
association	NULL
but	NULL
that	NULL
a	NULL
conservative	NULL
substitution	NULL
(	NULL
iso-leucine	NULL
for	NULL
leucine	NULL
)	NULL
can	NULL
be	NULL
tolerated	NULL
at	NULL
position	NULL
6	NULL
.	NULL

The	NULL
results	NULL
for	NULL
substitutions	NULL
in	NULL
«	NULL
-helix	NULL
4	NULL
show	NULL
that	NULL
a	NULL
mutation	NULL
of	NULL
the	NULL
proline	NULL
at	NULL
position	NULL
65	NULL
(	NULL
P65	NULL
)	NULL
which	NULL
causes	NULL
a	NULL
bend	NULL
in	NULL
this	NULL
«	NULL
-helix	NULL
(	NULL
23	NULL
)	NULL
did	NULL
not	NULL
disrupt	NULL
OCA-B	NULL
association	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
some	NULL
structural	NULL
changes	NULL
in	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
can	NULL
be	NULL
tolerated	NULL
without	NULL
necessarily	NULL
affecting	NULL
the	NULL
interaction	NULL
with	NULL
OCA-B	NULL
.	NULL

Alanine	NULL
substitution	NULL
for	NULL
the	NULL
methionine	NULL
at	NULL
position	NULL
60	NULL
(	NULL
M6OA	NULL
)	NULL
,	NULL
however	NULL
,	NULL
affected	NULL
OCA-B	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
;	NULL
this	NULL
residue	NULL
lies	NULL
between	NULL
the	NULL
major	NULL
groove	NULL
contacts	NULL
at	NULL
positions	NULL
5	NULL
and	NULL
6	NULL
of	NULL
the	NULL
octamer	NULL
site	NULL
on	NULL
one	NULL
side	NULL
and	NULL
POU	NULL
,	NULL
domain	NULL
residues	NULL
L6	NULL
and	NULL
E7	NULL
on	NULL
the	NULL
other	NULL
side	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
the	NULL
substitutions	NULL
that	NULL
affect	NULL
OCA-B	NULL
interaction	NULL
form	NULL
a	NULL
patch	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
region	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
contacts	NULL
OCA-B	NULL
.	NULL

We	NULL
assayed	NULL
14	NULL
alanine	NULL
substitutions	NULL
in	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
OCA-B	NULL
.	NULL

Unexpectedly	NULL
,	NULL
the	NULL
substitution	NULL
for	NULL
N51	NULL
,	NULL
which	NULL
is	NULL
conserved	NULL
in	NULL
nearly	NULL
all	NULL
ho-meodomains	NULL
and	NULL
makes	NULL
specific	NULL
base	NULL
contacts	NULL
in	NULL
homeodo-main-binding	NULL
sites	NULL
(	NULL
13	NULL
)	NULL
,	NULL
had	NULL
only	NULL
a	NULL
twofold	NULL
effect	NULL
on	NULL
binding	NULL
to	NULL
the	NULL
histone	NULL
H2B	NULL
octamer	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
;	NULL
compare	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
had	NULL
relatively	NULL
little	NULL
effect	NULL
on	NULL
DNA	NULL
binding	NULL
per	NULL
se	NULL
at	NULL
this	NULL
site	NULL
,	NULL
it	NULL
had	NULL
a	NULL
large	NULL
effect	NULL
on	NULL
OCA-B	NULL
association	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
13	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unlikely	NULL
that	NULL
OCA-B	NULL
contacts	NULL
this	NULL
asparagine	NULL
directly	NULL
because	NULL
it	NULL
is	NULL
not	NULL
exposed	NULL
when	NULL
the	NULL
POU	NULL
domain	NULL
is	NULL
bound	NULL
to	NULL
the	NULL
octamer	NULL
site	NULL
(	NULL
23	NULL
)	NULL
;	NULL
perhaps	NULL
the	NULL
precise	NULL
arrangement	NULL
of	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
on	NULL
the	NULL
DNA	NULL
is	NULL
critical	NULL
for	NULL
association	NULL
with	NULL
OCA-B	NULL
.	NULL

Only	NULL
3	NULL
of	NULL
the	NULL
other	NULL
13	NULL
alanine	NULL
substitutions	NULL
assayed	NULL
affected	NULL
association	NULL
with	NULL
OCA-B	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
16	NULL
)	NULL
,	NULL
substitutions	NULL
R13A	NULL
and	NULL
E17A	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
interaction	NULL
with	NULL
OCA-B	NULL
.	NULL

Two	NULL
mutations	NULL
,	NULL
E2ZA	NULL
and	NULL
E30A	NULL
,	NULL
which	NULL
prevent	NULL
VP16	NULL
interaction	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
25	NULL
,	NULL
39	NULL
,	NULL
40	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
to	NULL
interact	NULL
with	NULL
OCA-B	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
.	NULL

All	NULL
three	NULL
substitutions	NULL
that	NULL
did	NULL
affect	NULL
OCA-B	NULL
association	NULL
are	NULL
within	NULL
the	NULL
carboxy-terminal	NULL
region	NULL
of	NULL
«	NULL
-helix	NULL
3	NULL
,	NULL
the	NULL
DNA	NULL
recognition	NULL
helix	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lanes	NULL
18	NULL
and	NULL
19	NULL
,	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Figure	NULL
8	NULL
summarizes	NULL
these	NULL
results	NULL
.	NULL

It	NULL
shows	NULL
three	NULL
representations	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
site	NULL
cocrystal	NULL
structure	NULL
(	NULL
the	NULL
POU	NULL
domain	NULL
is	NULL
shown	NULL
in	NULL
white	NULL
,	NULL
and	NULL
DNA	NULL
is	NULL
shown	NULL
in	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
A.	NULL
Oct-1-OCA¥-B	NULL
COREGULATORY	NULL
FUNCTION	NULL
_	NULL
7301	NULL
Oct-1	NULL
POU	NULL
:	NULL
-	NULL
E	NULL
POUs	NULL
POUp	NULL
1	NULL
<	NULL
3	NULL
<	NULL
<	NULL
G	NULL
<	NULL
<	NULL
<	NULL
5	NULL
<	NULL
o	NULL
To	NULL
<	NULL
<	NULL
<	NULL
92	NULL
u	NULL
nov	NULL
a	NULL
n	NULL
s	NULL
{	NULL
G	NULL
soi	NULL
m	NULL
a	NULL
8	NULL
o	NULL
w	NULL
w	NULL
@	NULL
A	NULL
©	NULL
f	NULL
86	NULL
§	NULL
hg	NULL
§§	NULL
5	NULL
-5	NULL
rsf	NULL
dg	NULL
gts	NULL
OCA-B/POU	NULL
-	NULL
.	NULL

.	NULL

o	NULL
-	NULL
@	NULL
0O000	NULL
@	NULL
00	NULL
»	NULL
POU	NULL
~~~	NULL
R	NULL
@	NULL
@	NULL
@	NULL
@	NULL
00008	NULL
POU	NULL
m-r-	NULL
-	NULL
©OO0O0000000	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
»	NULL
«	NULL
0	NULL
0	NULL
08008	NULL
se	NULL
+	NULL
OCA-B	NULL
e	NULL
ao	NULL
e	NULL
s	NULL
se	NULL
-	NULL
000	NULL
06	NULL
-	NULL
OCA-B	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
OCTAMER	NULL
Oct-1	NULL
POUs	NULL
[	NULL
____a1	NULL
___	NULL
]	NULL
[	NULL
_	NULL
a2	NULL
]	NULL
_	NULL
[	NULL
Le3	NULL
|	NULL
]	NULL
|	NULL
Ce	NULL
|	NULL
EEPSDLEELEQFAKTFKORRIKLCF	NULL
TQGDVGLAMGKLYGNDFSQTT	NULL
I	NULL
SRFEALNLSFKNMCKLK	NULL
PLLEKWLNDAE	NULL
00	NULL
cee0ee0	NULL
00	NULL
00	NULL
Oct-1	NULL
POU	NULL
LU	NULL
©00800000	NULL
(	NULL
at	NULL
_	NULL
]	NULL
[	NULL
az	NULL
|	NULL
]	NULL
[	NULL
___a3	NULL
|	NULL
RRKKRTSTETNIRVALEKSFLENQKPTSE	NULL
00	NULL
o	NULL
EITMIADQLNMEKEVIRVWFCNRROKEKRIN	NULL
o	NULL
©0	NULL
_	NULL
©00000	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

OCA-B	NULL
interacts	NULL
with	NULL
multiple	NULL
residues	NULL
in	NULL
the	NULL
Oct-1	NULL
POUs	NULL
and	NULL
POUy	NULL
,	NULL
domains	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
retardation	NULL
analysis	NULL
of	NULL
a	NULL
representative	NULL
set	NULL
of	NULL
alanine	NULL
substitutions	NULL
in	NULL
the	NULL
Oct-1	NULL
POU	NULL
;	NULL
and	NULL
POUy	NULL
,	NULL
domains	NULL
.	NULL

In	NULL
vitro-translated	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
mutant	NULL
POU	NULL
domains	NULL
were	NULL
assayed	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
in	NULL
vitro-translated	NULL
OCA-B	NULL
with	NULL
the	NULL
histone	NULL
H2B	NULL
octamer	NULL
probe	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
each	NULL
POU	NULL
domain	NULL
is	NULL
indicated	NULL
above	NULL
the	NULL
corresponding	NULL
lane	NULL
.	NULL

POU	NULL
,	NULL
POU	NULL
domain-DNA-containing	NULL
complexes	NULL
;	NULL
OCA-B/POU	NULL
,	NULL
POU	NULL
domain-OCA-B-DNA-containing	NULL
complexes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
alanine	NULL
substitutions	NULL
in	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
on	NULL
Oct-1	NULL
POU	NULL
domain	NULL
association	NULL
with	NULL
OCA-B	NULL
,	NULL
as	NULL
assayed	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
retardation	NULL
analysis	NULL
.	NULL

The	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
and	NULL
POU	NULL
;	NULL
,	NULL
domains	NULL
are	NULL
shown	NULL
,	NULL
with	NULL
labeled	NULL
boxes	NULL
above	NULL
each	NULL
sequence	NULL
delineating	NULL
the	NULL
«	NULL
-helices	NULL
in	NULL
the	NULL
corresponding	NULL
POU	NULL
domain	NULL
.	NULL

Filled	NULL
and	NULL
open	NULL
circles	NULL
indicate	NULL
alanine	NULL
substitutions	NULL
that	NULL
disrupted	NULL
or	NULL
did	NULL
not	NULL
disrupt	NULL
association	NULL
with	NULL
OCA-B	NULL
,	NULL
respectively	NULL
.	NULL

gray	NULL
)	NULL
.	NULL

Positions	NULL
5	NULL
and	NULL
6	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
,	NULL
where	NULL
the	NULL
major	NULL
groove	NULL
of	NULL
DNA	NULL
is	NULL
critical	NULL
for	NULL
association	NULL
with	NULL
OCA-B	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
are	NULL
shown	NULL
in	NULL
green	NULL
.	NULL

Residues	NULL
whose	NULL
substitution	NULL
with	NULL
alanine	NULL
affected	NULL
OCA-B	NULL
interaction	NULL
are	NULL
highlighted	NULL
in	NULL
red	NULL
,	NULL
and	NULL
adjacent	NULL
residues	NULL
whose	NULL
substitution	NULL
did	NULL
not	NULL
affect	NULL
OCA-B	NULL
interaction	NULL
are	NULL
shown	NULL
in	NULL
blue	NULL
.	NULL

The	NULL
alanine	NULL
substitutions	NULL
that	NULL
did	NULL
not	NULL
affect	NULL
OCA-B	NULL
interaction	NULL
define	NULL
the	NULL
boundaries	NULL
of	NULL
the	NULL
OCA-B	NULL
interaction	NULL
surface	NULL
.	NULL

Shown	NULL
in	NULL
yellow	NULL
is	NULL
E22	NULL
,	NULL
the	NULL
glutamic	NULL
acid	NULL
residue	NULL
in	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
that	NULL
is	NULL
critical	NULL
for	NULL
VP16	NULL
association	NULL
(	NULL
25	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Figure	NULL
8A	NULL
shows	NULL
a	NULL
typical	NULL
projection	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
complex	NULL
,	NULL
with	NULL
the	NULL
POU	NULL
,	NULL
;	NULL
domain	NULL
to	NULL
the	NULL
upper	NULL
right	NULL
and	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
to	NULL
the	NULL
lower	NULL
left	NULL
,	NULL
revealing	NULL
the	NULL
amino-terminal	NULL
arm	NULL
of	NULL
the	NULL
POU	NULL
;	NULL
domain	NULL
.	NULL

In	NULL
this	NULL
projection	NULL
,	NULL
VP16	NULL
interacts	NULL
with	NULL
the	NULL
upper	NULL
right	NULL
surface	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
(	NULL
25	NULL
,	NULL
40	NULL
,	NULL
47	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
OCA-B	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
this	NULL
surface	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

Rotating	NULL
the	NULL
complex	NULL
along	NULL
the	NULL
horizontal	NULL
axis	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
reveals	NULL
the	NULL
OCA-B	NULL
interaction	NULL
surface	NULL
.	NULL

In	NULL
this	NULL
projection	NULL
,	NULL
the	NULL
major	NULL
groove	NULL
octamer	NULL
site	NULL
and	NULL
Oct-1	NULL
POU	NULL
domain	NULL
substitutions	NULL
that	NULL
affect	NULL
OCA-B	NULL
association	NULL
form	NULL
a	NULL
continuous	NULL
surface	NULL
that	NULL
links	NULL
the	NULL
POU	NULL
,	NULL
and	NULL
POU	NULL
;	NULL
domains	NULL
via	NULL
DNA	NULL
,	NULL
suggesting	NULL
that	NULL
OCA-B	NULL
contacts	NULL
the	NULL
two	NULL
POU	NULL
subdomains	NULL
and	NULL
the	NULL
octamer	NULL
sequence	NULL
simultaneously	NULL
.	NULL

Rotating	NULL
the	NULL
complex	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
along	NULL
the	NULL
vertical	NULL
axis	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
)	NULL
shows	NULL
how	NULL
the	NULL
two	NULL
POU	NULL
,	NULL
and	NULL
POU	NULL
,	NULL
domain	NULL
surfaces	NULL
that	NULL
interact	NULL
with	NULL
OCA-B	NULL
jut	NULL
out	NULL
from	NULL
the	NULL
Oct-1-DNA	NULL
complex	NULL
,	NULL
emphasizing	NULL
their	NULL
accessibility	NULL
for	NULL
interaction	NULL
with	NULL
a	NULL
coregulator	NULL
such	NULL
as	NULL
OCA-B	NULL
.	NULL

OCA-B	NULL
and	NULL
VP16	NULL
can	NULL
associate	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
simultaneously	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-OCA-B	NULL
interaction	NULL
surface	NULL
suggested	NULL
that	NULL
OCA-B	NULL
and	NULL
VP16	NULL
target	NULL
separate	NULL
surfaces	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hy-pothesis	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
OCA-B	NULL
and	NULL
VP16	NULL
can	NULL
interact	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
simultaneously	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
by	NULL
a	NULL
single	NULL
base	NULL
pair	NULL
substitution	NULL
,	NULL
we	NULL
changed	NULL
an	NULL
(	NULL
OCTA	NULL
VP16-responsive	NULL
element	NULL
from	NULL
the	NULL
HSV	NULL
ICPO	NULL
promoter	NULL
to	NULL
contain	NULL
a	NULL
consensus	NULL
overlapping	NULL
octamer	NULL
sequence	NULL
,	NULL
thus	NULL
creating	NULL
the	NULL
ICPO	NULL
perfect	NULL
octamer	NULL
site	NULL
(	NULL
ATGCAAATGATAT	NULL
)	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
OCA-B	NULL
and	NULL
VP16	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
on	NULL
this	NULL
site	NULL
in	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
retardation	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
4	NULL
,	NULL
12	NULL
,	NULL
16	NULL
)	NULL
,	NULL
the	NULL
wild-type	NULL
Oct-1	NULL
POU	NULL
domain	NULL
associated	NULL
with	NULL
either	NULL
OCA-B	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
VP16	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
on	NULL
the	NULL
ICPO	NULL
perfect	NULL
octamer	NULL
site	NULL
.	NULL

When	NULL
7302	NULL
BABB	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

FIG	NULL
.	NULL

8	NULL
.	NULL

Graphic	NULL
representation	NULL
of	NULL
the	NULL
OCA-B	NULL
interaction	NULL
surface	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
site	NULL
complex	NULL
.	NULL

The	NULL
molecular	NULL
modeling	NULL
program	NULL
GRASP	NULL
(	NULL
34	NULL
)	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
three	NULL
projections	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
site	NULL
complex	NULL
(	NULL
23	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
this	NULL
projection	NULL
,	NULL
the	NULL
octamer	NULL
sequence	NULL
ATGCAAAT	NULL
is	NULL
shown	NULL
from	NULL
left	NULL
to	NULL
right	NULL
,	NULL
with	NULL
the	NULL
POU	NULL
;	NULL
,	NULL
domain	NULL
to	NULL
the	NULL
upper	NULL
right	NULL
and	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
to	NULL
the	NULL
lower	NULL
left	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Shown	NULL
is	NULL
a	NULL
180°	NULL
rotation	NULL
along	NULL
the	NULL
horizontal	NULL
axis	NULL
of	NULL
the	NULL
projection	NULL
in	NULL
panel	NULL
A	NULL
,	NULL
with	NULL
the	NULL
POU	NULL
;	NULL
domain	NULL
to	NULL
the	NULL
lower	NULL
right	NULL
and	NULL
the	NULL
POUs	NULL
domain	NULL
to	NULL
the	NULL
upper	NULL
left	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Shown	NULL
is	NULL
a	NULL
90°	NULL
counterclockwise	NULL
rotation	NULL
,	NULL
looking	NULL
down	NULL
the	NULL
vertical	NULL
axis	NULL
of	NULL
the	NULL
projection	NULL
in	NULL
panel	NULL
A	NULL
in	NULL
such	NULL
a	NULL
way	NULL
that	NULL
the	NULL
octamer	NULL
sequence	NULL
ATGCAAAT	NULL
goes	NULL
away	NULL
from	NULL
the	NULL
viewer	NULL
,	NULL
the	NULL
POUy	NULL
;	NULL
domain	NULL
is	NULL
on	NULL
top	NULL
,	NULL
and	NULL
the	NULL
POUs	NULL
domain	NULL
is	NULL
on	NULL
the	NULL
bottom	NULL
.	NULL

In	NULL
this	NULL
projection	NULL
,	NULL
the	NULL
POU	NULL
domain	NULL
linker	NULL
is	NULL
predicted	NULL
to	NULL
lie	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
DNA	NULL
.	NULL

In	NULL
all	NULL
three	NULL
projections	NULL
,	NULL
the	NULL
POU	NULL
domain	NULL
is	NULL
shown	NULL
in	NULL
white	NULL
and	NULL
DNA	NULL
is	NULL
shown	NULL
in	NULL
gray	NULL
.	NULL

Residues	NULL
whose	NULL
substitution	NULL
by	NULL
alanine	NULL
disrupted	NULL
OCA-B	NULL
association	NULL
are	NULL
shown	NULL
in	NULL
red	NULL
,	NULL
and	NULL
neighboring	NULL
residues	NULL
whose	NULL
substitution	NULL
by	NULL
alanine	NULL
did	NULL
not	NULL
disrupt	NULL
OCA-B	NULL
association	NULL
are	NULL
shown	NULL
in	NULL
blue	NULL
.	NULL

The	NULL
two	NULL
base	NULL
pairs	NULL
that	NULL
disrupted	NULL
OCA-B	NULL
association	NULL
selectively	NULL
when	NULL
they	NULL
were	NULL
replaced	NULL
by	NULL
IC	NULL
are	NULL
shown	NULL
in	NULL
green	NULL
.	NULL

Shown	NULL
in	NULL
yellow	NULL
is	NULL
E22	NULL
,	NULL
the	NULL
glutamic	NULL
acid	NULL
residue	NULL
in	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
that	NULL
is	NULL
critical	NULL
for	NULL
VP16	NULL
association	NULL
(	NULL
25	NULL
,	NULL
40	NULL
)	NULL
.	NULL

VP16	NULL
and	NULL
OCA-B	NULL
were	NULL
added	NULL
together	NULL
in	NULL
either	NULL
the	NULL
presence	NULL
OCA-B	NULL
but	NULL
not	NULL
VP16	NULL
association	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lanes	NULL
9	NULL
through	NULL
12	NULL
)	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
of	NULL
HCF	NULL
,	NULL
a	NULL
novel	NULL
and	NULL
the	NULL
POU	NULL
;	NULL
;	NULL
>	NULL
;	NULL
,	NULL
mutation	NULL
,	NULL
which	NULL
prevented	NULL
VP16	NULL
but	NULL
not	NULL
complex	NULL
of	NULL
reduced	NULL
mobility	NULL
was	NULL
evident	NULL
.	NULL

This	NULL
novel	NULL
complex	NULL
OCA-B	NULL
association	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lanes	NULL
13	NULL
through	NULL
16	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
was	NULL
affected	NULL
by	NULL
both	NULL
the	NULL
POU	NULL
;	NULL
;	NULL
;	NULL
,	NULL
,	NULL
mutation	NULL
,	NULL
which	NULL
prevented	NULL
novel	NULL
complex	NULL
probably	NULL
represents	NULL
simultaneous	NULL
association	NULL
of	NULL
POUs.e7n	NULL
-	NULL
+	NULL
Oct-1	NULL
POU	NULL
:	NULL
-	NULL
WT	NULL
POUS-E7R	NULL
POUH-EZZA	NULL
POUH-E22A	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
U	NULL
I	NULL
U	NULL
E	NULL
__	NULL
I	NULL
VP16	NULL
:	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
OCA	NULL
-B	NULL
:	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
£	NULL
T	NULL
OCA-B/AVIC	NULL
~	NULL
#	NULL
«	NULL
#	NULL
#	NULL
wt	NULL
VIC	NULL
OCA-B/POU	NULL
-	NULL
«	NULL
a	NULL
wae	NULL
e	NULL
cas	NULL
Pou	NULL
-	NULL
e	NULL
@	NULL
8ss6s	NULL
sesso	NULL
@	NULL
€	NULL
@	NULL
@	NULL
@	NULL
-r	NULL
--	NULL
LPOR®	NULL
DODO	NULL
OOOO	NULL
©000	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
ICPO	NULL
PERFECT	NULL
OCTAMER	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

OCA-B	NULL
and	NULL
VP16	NULL
interact	NULL
with	NULL
separate	NULL
surfaces	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

The	NULL
results	NULL
of	NULL
electrophoretic	NULL
mobility	NULL
retardation	NULL
analysis	NULL
of	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
mutant	NULL
Oct-1	NULL
POU	NULL
domains	NULL
for	NULL
OCA-B	NULL
and	NULL
VP16	NULL
association	NULL
on	NULL
the	NULL
ICPO	NULL
perfect	NULL
octamer	NULL
site	NULL
are	NULL
shown	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
;	NULL
lanes	NULL
1	NULL
through	NULL
4	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
WT	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
lanes	NULL
5	NULL
through	NULL
8	NULL
)	NULL
,	NULL
the	NULL
(	NULL
lanes	NULL
9	NULL
through	NULL
12	NULL
)	NULL
or	NULL
POU	NULL
(	NULL
lanes	NULL
13	NULL
through	NULL
16	NULL
)	NULL
single	NULL
mutant	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
or	NULL
the	NULL
POUsp	NULL
;	NULL
gq	NULL
+	NULL
POUp.p	NULL
>	NULL
>	NULL
a	NULL
double	NULL
mutant	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
lanes	NULL
17	NULL
through	NULL
20	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
of	NULL
OCA-B	NULL
or	NULL
VP16AC	NULL
and	NULL
HCF	NULL
,	NULL
s	NULL
,	NULL
(	NULL
VP16	NULL
)	NULL
in	NULL
each	NULL
sample	NULL
is	NULL
indicated	NULL
above	NULL
the	NULL
corresponding	NULL
lane	NULL
.	NULL

OCA-B	NULL
,	NULL
Oct-1	NULL
POU	NULL
domains	NULL
,	NULL
and	NULL
HCF	NULL
,	NULL
,	NULL
,	NULL
were	NULL
synthesized	NULL
by	NULL
translation	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
VP16AC	NULL
was	NULL
synthesized	NULL
in	NULL
£	NULL
.	NULL

coli	NULL
.	NULL

POU	NULL
,	NULL
POU	NULL
domain-DNA-containing	NULL
complexes	NULL
;	NULL
OCA-B/POU	NULL
,	NULL
POU	NULL
domain-OCA-B-DNA-containing	NULL
complexes	NULL
;	NULL
VIC	NULL
,	NULL
VP16-induced	NULL
complex	NULL
;	NULL
OCA-B/VIC	NULL
,	NULL
OCA-B-containing	NULL
VP16-induced	NULL
complex	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
OCA-B	NULL
and	NULL
VP16	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

By	NULL
combining	NULL
the	NULL
OCA	NULL
POU	NULL
,	NULL
;	NULL
;	NULL
,	NULL
,	NULL
mutation	NULL
and	NULL
the	NULL
VP16-specific	NULL
POU	NULL
;	NULL
;	NULL
;	NULL
;	NULL
,	NULL
>	NULL
,	NULL
mutation	NULL
,	NULL
we	NULL
created	NULL
a	NULL
variant	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
Oct-1	NULL
POUsp	NULL
;	NULL
g	NULL
+	NULL
POUpp	NULL
;	NULL
>	NULL
41	NULL
)	NULL
that	NULL
recognized	NULL
DNA	NULL
effectively	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lane	NULL
17	NULL
)	NULL
but	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
either	NULL
OCA-B	NULL
or	NULL
VP16	NULL
(	NULL
lanes	NULL
18	NULL
through	NULL
20	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
OCA-B	NULL
and	NULL
VP16	NULL
to	NULL
associate	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
simultaneously	NULL
on	NULL
a	NULL
single	NULL
DNA	NULL
site	NULL
indicates	NULL
that	NULL
although	NULL
OCA-B	NULL
and	NULL
VP16	NULL
affect	NULL
the	NULL
function	NULL
of	NULL
Oct-1	NULL
similarly	NULL
,	NULL
they	NULL
interact	NULL
with	NULL
separate	NULL
protein	NULL
and	NULL
DNA	NULL
surfaces	NULL
of	NULL
the	NULL
DNA-bound	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

DISCUSSION	NULL
We	NULL
analyzed	NULL
the	NULL
function	NULL
of	NULL
the	NULL
B-cell-specific	NULL
Oct-1	NULL
coregulator	NULL
OCA-B	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
OCA-B	NULL
shares	NULL
functions	NULL
with	NULL
the	NULL
viral	NULL
Oct-1	NULL
coregulator	NULL
VP16	NULL
.	NULL

Both	NULL
change	NULL
the	NULL
transcriptional	NULL
activation	NULL
potential	NULL
of	NULL
Oct-1	NULL
and	NULL
recruit	NULL
Oct-1	NULL
to	NULL
cis-regulatory	NULL
sites	NULL
.	NULL

They	NULL
achieve	NULL
these	NULL
functions	NULL
,	NULL
however	NULL
,	NULL
through	NULL
completely	NULL
different	NULL
interactions	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
and	NULL
DNA	NULL
.	NULL

OCA	NULL
-B	NULL
interacts	NULL
with	NULL
a	NULL
continuous	NULL
surface	NULL
of	NULL
the	NULL
DNA-bound	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
encompassing	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
,	NULL
the	NULL
central	NULL
region	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
,	NULL
and	NULL
the	NULL
POU	NULL
;	NULL
domain	NULL
,	NULL
whereas	NULL
VP16	NULL
interacts	NULL
with	NULL
a	NULL
different	NULL
surface	NULL
of	NULL
the	NULL
POU	NULL
;	NULL
domain	NULL
and	NULL
with	NULL
sequences	NULL
3	NULL
'	NULL
of	NULL
the	NULL
octamer	NULL
sequence	NULL
.	NULL

These	NULL
two	NULL
surfaces	NULL
are	NULL
sufficiently	NULL
different	NULL
that	NULL
these	NULL
two	NULL
Oct-1	NULL
coregulators	NULL
can	NULL
associate	NULL
with	NULL
Oct-1	NULL
simultaneously	NULL
.	NULL

The	NULL
POU	NULL
domain	NULL
offers	NULL
flexibility	NULL
in	NULL
both	NULL
protein-DNA	NULL
and	NULL
protein-protein	NULL
interactions	NULL
.	NULL

POU	NULL
domain	NULL
proteins	NULL
display	NULL
considerable	NULL
flexibility	NULL
in	NULL
their	NULL
interactions	NULL
with	NULL
DNA	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Mutagenesis	NULL
studies	NULL
of	NULL
Brn-2	NULL
and	NULL
Oct-1	NULL
(	NULL
6	NULL
,	NULL
27	NULL
,	NULL
56	NULL
)	NULL
and	NULL
DNA	NULL
cross-linking	NULL
studies	NULL
(	NULL
7	NULL
)	NULL
have	NULL
revealed	NULL
that	NULL
individual	NULL
POU	NULL
domains	NULL
can	NULL
adopt	NULL
different	NULL
conformations	NULL
on	NULL
different	NULL
cis-regulatory	NULL
sites	NULL
.	NULL

Indeed	NULL
,	NULL
even	NULL
on	NULL
a	NULL
single	NULL
cis-regulatory	NULL
site	NULL
,	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
can	NULL
adopt	NULL
more	NULL
than	NULL
one	NULL
conformation	NULL
.	NULL

When	NULL
it	NULL
is	NULL
bound	NULL
to	NULL
a	NULL
VP16-responsive	NULL
TAATGARAT	NULL
site	NULL
containing	NULL
an	NULL
overlapping	NULL
octamer	NULL
sequence	NULL
,	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
can	NULL
bind	NULL
both	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
of	NULL
the	NULL
POU	NULL
,	NULL
;	NULL
domain	NULL
;	NULL
surprisingly	NULL
,	NULL
both	NULL
of	NULL
these	NULL
conformations	NULL
are	NULL
compatible	NULL
with	NULL
VP16	NULL
association	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
POU	NULL
domain	NULL
also	NULL
displays	NULL
great	NULL
flexibility	NULL
in	NULL
its	NULL
interactions	NULL
with	NULL
other	NULL
proteins	NULL
.	NULL

Previous	NULL
analyses	NULL
of	NULL
Oct-1	NULL
POU	NULL
domain	NULL
mutations	NULL
that	NULL
disrupt	NULL
interactions	NULL
with	NULL
Oct-1	NULL
coregulators	NULL
have	NULL
shown	NULL
that	NULL
VP16	NULL
interacts	NULL
with	NULL
the	NULL
POU	NULL
;	NULL
domain	NULL
(	NULL
41	NULL
,	NULL
47	NULL
)	NULL
and	NULL
that	NULL
SNAP	NULL
,	NULL
interacts	NULL
with	NULL
the	NULL
POU	NULL
domain	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
SNAP	NULL
,	NULL
also	NULL
interacts	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
;	NULL
domain	NULL
,	NULL
our	NULL
study	NULL
has	NULL
shown	NULL
that	NULL
OCA-B	NULL
interacts	NULL
with	NULL
both	NULL
the	NULL
POU	NULL
and	NULL
POU	NULL
;	NULL
domains	NULL
.	NULL

The	NULL
simultaneous	NULL
interaction	NULL
of	NULL
OCA-B	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
and	NULL
POU	NULL
;	NULL
domains	NULL
and	NULL
with	NULL
the	NULL
DNA	NULL
between	NULL
the	NULL
two	NULL
POU	NULL
DNA-binding	NULL
structures	NULL
suggests	NULL
that	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
and	NULL
OCA-B	NULL
form	NULL
a	NULL
linked	NULL
structure	NULL
surrounding	NULL
the	NULL
octamer	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
ring-like	NULL
structure	NULL
may	NULL
form	NULL
a	NULL
stable	NULL
complex	NULL
for	NULL
high-level	NULL
and	NULL
long-term	NULL
activation	NULL
of	NULL
Ig	NULL
gene	NULL
transcription	NULL
in	NULL
differentiated	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
bipartite	NULL
pattern	NULL
of	NULL
OCA-B	NULL
interaction	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
suggests	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
VP16	NULL
,	NULL
which	NULL
can	NULL
associate	NULL
with	NULL
Oct-1	NULL
when	NULL
the	NULL
Oct-1	NULL
POU	NULL
,	NULL
domain	NULL
is	NULL
in	NULL
different	NULL
positions	NULL
(	NULL
7	NULL
)	NULL
,	NULL
the	NULL
precise	NULL
positioning	NULL
of	NULL
the	NULL
two	NULL
POU	NULL
domain	NULL
DNA-binding	NULL
structures	NULL
is	NULL
critical	NULL
for	NULL
OCA-B	NULL
associ-ation	NULL
.	NULL

Consistent	NULL
with	NULL
such	NULL
differences	NULL
in	NULL
how	NULL
VP16	NULL
and	NULL
OCA-B	NULL
interact	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
VP16	NULL
can	NULL
associate	NULL
with	NULL
Oct-1	NULL
when	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
carries	NULL
the	NULL
R49¥A	NULL
POU	NULL
,	NULL
domain	NULL
DNA	NULL
recognition	NULL
helix	NULL
mutation	NULL
,	NULL
which	NULL
disrupts	NULL
POU	NULL
,	NULL
domain	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
this	NULL
mutation	NULL
Oct-1-OCA¥-B	NULL
COREGULATORY	NULL
FUNCTION	NULL
-	NULL
7303	NULL
prevented	NULL
OCA-B	NULL
association	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
on	NULL
the	NULL
octamer	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
although	NULL
the	NULL
NS1A	NULL
substitution	NULL
in	NULL
the	NULL
POU	NULL
;	NULL
domain	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
POU	NULL
domain	NULL
binding	NULL
to	NULL
the	NULL
histone	NULL
H2B	NULL
octamer	NULL
,	NULL
it	NULL
had	NULL
a	NULL
major	NULL
effect	NULL
on	NULL
OCA-B	NULL
association	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
precise	NULL
configuration	NULL
of	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
on	NULL
DNA	NULL
is	NULL
also	NULL
critical	NULL
for	NULL
Oct-1	NULL
POU	NULL
domain	NULL
association	NULL
with	NULL
OCA-B	NULL
.	NULL

Whichever	NULL
Oct-1	NULL
POU	NULL
domain	NULL
conformation	NULL
OCA-B	NULL
recognizes	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
to	NULL
associate	NULL
simultaneously	NULL
with	NULL
OCA-B	NULL
and	NULL
VP16	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
demonstrates	NULL
that	NULL
these	NULL
two	NULL
Oct-1	NULL
coregulators	NULL
can	NULL
recognize	NULL
the	NULL
same	NULL
conformation	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
independent	NULL
interactions	NULL
of	NULL
OCA-B	NULL
and	NULL
VP16	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
the	NULL
associations	NULL
of	NULL
OCA-B	NULL
and	NULL
SNAP	NULL
,	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
are	NULL
sensitive	NULL
to	NULL
the	NULL
same	NULL
single	NULL
amino	NULL
acid	NULL
substitution	NULL
,	NULL
the	NULL
E7R	NULL
Oct-1-Pit-1	NULL
exchange	NULL
in	NULL
the	NULL
POU	NULL
,	NULL
domain	NULL
.	NULL

Consistent	NULL
with	NULL
overlapping	NULL
OCA-B	NULL
and	NULL
SNAP	NULL
,	NULL
interactions	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
in	NULL
a	NULL
transient-expression	NULL
assay	NULL
,	NULL
OCA-B	NULL
is	NULL
able	NULL
to	NULL
interfere	NULL
with	NULL
octamer-dependent	NULL
activation	NULL
of	NULL
UZ	NULL
snRNA	NULL
gene	NULL
transcription	NULL
(	NULL
2	NULL
)	NULL
.	NULL

How	NULL
do	NULL
these	NULL
competing	NULL
interactions	NULL
not	NULL
interfere	NULL
with	NULL
one	NULL
another	NULL
on	NULL
an	NULL
snRNA	NULL
promoter	NULL
in	NULL
a	NULL
B	NULL
cell	NULL
?	NULL

Probably	NULL
,	NULL
under	NULL
natural	NULL
conditions	NULL
,	NULL
promoter-specific	NULL
interactions	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
those	NULL
of	NULL
promoter-selective	NULL
activation	NULL
domains	NULL
)	NULL
stabilize	NULL
the	NULL
appropriate	NULL
Oct-1	NULL
POU	NULL
domain	NULL
interaction	NULL
and	NULL
prevent	NULL
com-petition	NULL
.	NULL

Together	NULL
,	NULL
the	NULL
versatility	NULL
and	NULL
flexibility	NULL
displayed	NULL
by	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
in	NULL
both	NULL
DNA	NULL
sequence	NULL
recognition	NULL
and	NULL
coregulator	NULL
association	NULL
reveal	NULL
a	NULL
DNA-binding	NULL
domain	NULL
which	NULL
can	NULL
adapt	NULL
itself	NULL
to	NULL
many	NULL
promoter	NULL
contexts	NULL
.	NULL

This	NULL
versatility	NULL
and	NULL
flexibility	NULL
may	NULL
result	NULL
from	NULL
the	NULL
unusual	NULL
structural	NULL
characteristics	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
,	NULL
in	NULL
which	NULL
two	NULL
independent	NULL
DNA-binding	NULL
structures	NULL
,	NULL
the	NULL
POU	NULL
,	NULL
and	NULL
POU	NULL
,	NULL
,	NULL
domains	NULL
,	NULL
are	NULL
joined	NULL
by	NULL
a	NULL
flexible	NULL
linker	NULL
.	NULL

This	NULL
structural	NULL
arrangement	NULL
provides	NULL
not	NULL
only	NULL
flexibility	NULL
in	NULL
how	NULL
the	NULL
POU	NULL
domain	NULL
binds	NULL
DNA	NULL
but	NULL
also	NULL
diverse	NULL
surfaces	NULL
for	NULL
interaction	NULL
with	NULL
coregulators	NULL
.	NULL

Two	NULL
mechanisms	NULL
by	NULL
which	NULL
an	NULL
octamer	NULL
motif	NULL
can	NULL
achieve	NULL
B-cell-specific	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
a	NULL
typical	NULL
mRNA-type	NULL
promoter	NULL
,	NULL
the	NULL
octamer	NULL
motif	NULL
displays	NULL
B-cell-specific	NULL
activation	NULL
of	NULL
transcription	NULL
(	NULL
11	NULL
,	NULL
14	NULL
,	NULL
26	NULL
,	NULL
59	NULL
)	NULL
.	NULL

One	NULL
explanation	NULL
for	NULL
this	NULL
specificity	NULL
is	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
Oct-l-related	NULL
POU	NULL
domain	NULL
protein	NULL
Oct-2	NULL
(	NULL
8	NULL
,	NULL
33	NULL
,	NULL
43	NULL
,	NULL
49	NULL
)	NULL
,	NULL
which	NULL
has	NULL
the	NULL
same	NULL
octamer	NULL
motif-binding	NULL
specificity	NULL
(	NULL
46	NULL
)	NULL
but	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
Oct-1	NULL
,	NULL
contains	NULL
activation	NULL
domains	NULL
which	NULL
more	NULL
effectively	NULL
activate	NULL
mRNA-type	NULL
promoters	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

B-cell-specific	NULL
OCA-B	NULL
,	NULL
with	NULL
its	NULL
mRNA-type	NULL
promoter-selective	NULL
activation	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
provides	NULL
a	NULL
second	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
octamer	NULL
motif	NULL
can	NULL
display	NULL
B-cell-specific	NULL
transcription	NULL
.	NULL

Its	NULL
association	NULL
with	NULL
Oct-1	NULL
,	NULL
a	NULL
generally	NULL
ineffective	NULL
activator	NULL
of	NULL
mRNA-type	NULL
promoters	NULL
(	NULL
52	NULL
)	NULL
,	NULL
allows	NULL
activation	NULL
of	NULL
mRNA-type	NULL
promoters	NULL
(	NULL
4	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
29	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
,	NULL
very	NULL
similar	NULL
to	NULL
what	NULL
VP16	NULL
does	NULL
on	NULL
HSV	NULL
promoters	NULL
(	NULL
36	NULL
,	NULL
54	NULL
)	NULL
.	NULL

These	NULL
two	NULL
mechanisms	NULL
by	NULL
which	NULL
B-cell-specific	NULL
octamer	NULL
motif	NULL
function	NULL
is	NULL
achieved	NULL
apparently	NULL
evolved	NULL
separately	NULL
.	NULL

Oct-1	NULL
and	NULL
Oct-2	NULL
arose	NULL
through	NULL
gene	NULL
duplication	NULL
(	NULL
19	NULL
)	NULL
,	NULL
whereas	NULL
OCA-B	NULL
probably	NULL
arose	NULL
by	NULL
a	NULL
different	NULL
mechanism	NULL
.	NULL

Why	NULL
have	NULL
two	NULL
mechanisms	NULL
for	NULL
B-cell-specific	NULL
octamer	NULL
motif-dependent	NULL
transcription	NULL
arisen	NULL
?	NULL

Perhaps	NULL
they	NULL
provide	NULL
flexibility	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
B-cell-specific	NULL
transcription	NULL
.	NULL

For	NULL
example	NULL
,	NULL
although	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-1	NULL
provides	NULL
for	NULL
activation	NULL
of	NULL
an	NULL
mRNA-type	NULL
promoter	NULL
,	NULL
OCA-B	NULL
association	NULL
with	NULL
Oct-2	NULL
may	NULL
provide	NULL
even	NULL
higher	NULL
levels	NULL
of	NULL
mRNA-type	NULL
promoter	NULL
transcription	NULL
or	NULL
transcriptional	NULL
activation	NULL
from	NULL
more	NULL
distal	NULL
regulatory	NULL
elements	NULL
,	NULL
such	NULL
as	NULL
enhancers	NULL
(	NULL
37	NULL
)	NULL
,	NULL
because	NULL
of	NULL
the	NULL
combination	NULL
of	NULL
mRNA-type	NULL
promoter-selective	NULL
activation	NULL
domains	NULL
provided	NULL
by	NULL
both	NULL
OCA-B	NULL
and	NULL
Oct-2	NULL
.	NULL

Furthermore	NULL
,	NULL
OCA-B	NULL
stabilizes	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
and	NULL
probably	NULL
the	NULL
7304	NULL
BABB	NULL
ET	NULL
AL	NULL
.	NULL

Oct-2	NULL
POU	NULL
domain	NULL
)	NULL
on	NULL
low-affinity	NULL
octamer	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
allowing	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
from	NULL
promoters	NULL
that	NULL
would	NULL
be	NULL
silent	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
OCA-B	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
Oct-2	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
OCA-B	NULL
,	NULL
promoters	NULL
with	NULL
low-affinity	NULL
octamer	NULL
sites	NULL
can	NULL
respond	NULL
to	NULL
either	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
;	NULL
however	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
OCA-B	NULL
,	NULL
only	NULL
mRNA-type	NULL
promoters	NULL
with	NULL
high-affinity	NULL
octamer	NULL
sites	NULL
should	NULL
be	NULL
active	NULL
,	NULL
because	NULL
of	NULL
the	NULL
mRNA-type	NULL
transcriptional	NULL
activation	NULL
domain	NULL
activity	NULL
of	NULL
Oct-2	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
functional	NULL
redundancy	NULL
of	NULL
an	NULL
OCA-B-Oct-1	NULL
complex	NULL
and	NULL
Oct-2	NULL
alone	NULL
,	NULL
gene	NULL
disruption	NULL
of	NULL
OCA-B	NULL
(	NULL
22	NULL
,	NULL
44	NULL
)	NULL
or	NULL
Oct-2	NULL
(	NULL
9	NULL
)	NULL
does	NULL
not	NULL
impair	NULL
Ig	NULL
gene	NULL
transcription	NULL
in	NULL
early	NULL
B	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
mice	NULL
deficient	NULL
for	NULL
either	NULL
OCA-B	NULL
or	NULL
Oct-2	NULL
do	NULL
display	NULL
different	NULL
phenotypes	NULL
,	NULL
and	NULL
some	NULL
of	NULL
these	NULL
differences	NULL
may	NULL
result	NULL
from	NULL
the	NULL
different	NULL
activities	NULL
of	NULL
OCA-B	NULL
and	NULL
Oct-2	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
reveal	NULL
that	NULL
through	NULL
the	NULL
generation	NULL
of	NULL
families	NULL
of	NULL
related	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
,	NULL
or	NULL
by	NULL
using	NULL
coregulators	NULL
,	NULL
such	NULL
as	NULL
OCA-B	NULL
,	NULL
flexibility	NULL
and	NULL
complexity	NULL
in	NULL
cell-specific	NULL
transcription	NULL
can	NULL
be	NULL
achieved	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
D.	NULL
Aufiero	NULL
for	NULL
help	NULL
with	NULL
mutagenesis	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
;	NULL
M.	NULL
Tanaka	NULL
and	NULL
W.	NULL
Tansey	NULL
for	NULL
advice	NULL
and	NULL
discussions	NULL
;	NULL
L.	NULL
Joshua-Tor	NULL
for	NULL
help	NULL
with	NULL
the	NULL
structure	NULL
representation	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-octamer	NULL
site	NULL
complex	NULL
;	NULL
and	NULL
N.	NULL
Hernandez	NULL
,	NULL
W.	NULL
Tansey	NULL
,	NULL
and	NULL
T.	NULL
Volpe	NULL
for	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
supported	NULL
by	NULL
PHS	NULL
grant	NULL
CA13106	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Aurora	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1992	NULL
.	NULL

Segments	NULL
of	NULL
the	NULL
POU	NULL
domain	NULL
influence	NULL
one	NULL
another	NULL
's	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:455-467	NULL
.	NULL

2	NULL
.	NULL

Babb	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

Unpublished	NULL
results	NULL
.	NULL

3	NULL
.	NULL

Bodner	NULL
,	NULL
M.	NULL
,	NULL
J.-L.	NULL
Castrillo	NULL
,	NULL
L.	NULL
E.	NULL
Theill	NULL
,	NULL
T.	NULL
Deerinck	NULL
,	NULL
M.	NULL
Ellisman	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
pituitary-specific	NULL
transcription	NULL
factor	NULL
GHF-1	NULL
is	NULL
a	NULL
ho-meobox-containing	NULL
protein	NULL
.	NULL

Cell	NULL
55:505-518	NULL
.	NULL

4	NULL
.	NULL

Cepek	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
D.	NULL
I.	NULL
Chasman	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1996	NULL
.	NULL

Sequence-specific	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
B-cell-specific	NULL
coactivator	NULL
OCA-B	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:2079-2088	NULL
.	NULL

5	NULL
.	NULL

Cleary	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
S.	NULL
Stern	NULL
,	NULL
M.	NULL
Tanaka	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
positive	NULL
control	NULL
by	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
transcriptionally	NULL
silent	NULL
motif	NULL
through	NULL
Oct-1	NULL
and	NULL
VP16	NULL
corecruitment	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:72-83	NULL
.	NULL

6	NULL
.	NULL

Cleary	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1995	NULL
.	NULL

Mechanisms	NULL
for	NULL
flexibility	NULL
in	NULL
DNA	NULL
sequence	NULL
recognition	NULL
and	NULL
VP16-induced	NULL
complex	NULL
formation	NULL
by	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2090-2100	NULL
.	NULL

7	NULL
.	NULL

Cleary	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
P.	NULL
S.	NULL
Pendergrast	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1997	NULL
.	NULL

Structural	NULL
flexibility	NULL
in	NULL
transcription	NULL
complex	NULL
formation	NULL
revealed	NULL
by	NULL
protein-DNA	NULL
photocrosslink-ing	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:8450-8455	NULL
.	NULL

8	NULL
.	NULL

Clerc	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
L.	NULL
M.	NULL
Corcoran	NULL
,	NULL
J.	NULL
H.	NULL
LeBowitz	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
B-cell-specific	NULL
Oct-2	NULL
protein	NULL
contains	NULL
POU	NULL
box-	NULL
and	NULL
homeo	NULL
box-type	NULL
domains	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

21570-1581	NULL
.	NULL

9	NULL
.	NULL

Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
M.	NULL
Karvelas	NULL
,	NULL
G.	NULL
J.	NULL
V.	NULL
Nossal	NULL
,	NULL
Z.-S.	NULL
Ye	NULL
,	NULL
T.	NULL
Jacks	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

Oct-2	NULL
,	NULL
although	NULL
not	NULL
required	NULL
for	NULL
early	NULL
B-cell	NULL
development	NULL
,	NULL
is	NULL
critical	NULL
for	NULL
later	NULL
B-cell	NULL
maturation	NULL
and	NULL
for	NULL
postnatal	NULL
survival	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:570-582	NULL
.	NULL

10	NULL
.	NULL

Das	NULL
,	NULL
G.	NULL
,	NULL
C.	NULL
S.	NULL
Hinkley	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1995	NULL
.	NULL

Basal	NULL
promoter	NULL
elements	NULL
as	NULL
a	NULL
selective	NULL
determinant	NULL
of	NULL
transcriptional	NULL
activator	NULL
function	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
374:657-660	NULL
.	NULL

11	NULL
.	NULL

Davidson	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Fromental	NULL
,	NULL
P.	NULL
Augereau	NULL
,	NULL
A.	NULL
Wildeman	NULL
,	NULL
M.	NULL
Zenke	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1986	NULL
.	NULL

Cell-type	NULL
specific	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
enhancer	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
in	NULL
nuclear	NULL
extracts	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323:544-548	NULL
.	NULL

12	NULL
.	NULL

Douville	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Hagmann	NULL
,	NULL
O.	NULL
Georgiev	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1995	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
regulation	NULL
at	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
ICP4	NULL
and	NULL
ICPO	NULL
TAATGAR	NULL
AT	NULL
motifs	NULL
.	NULL

Virology	NULL
207:107-116	NULL
.	NULL

13	NULL
.	NULL

Gehring	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Y.	NULL
Q.	NULL
Qian	NULL
,	NULL
M.	NULL
Billeter	NULL
,	NULL
K.	NULL
Furukubo-Tokunaga	NULL
,	NULL
A.	NULL
F.	NULL
Schier	NULL
,	NULL
D.	NULL
Resendez-Perez	NULL
,	NULL
M.	NULL
Affolter	NULL
,	NULL
G.	NULL
Otting	NULL
,	NULL
and	NULL
K.	NULL
Wuthrich	NULL
.	NULL

1994	NULL
.	NULL

Home-odomain-DNA	NULL
recognition	NULL
.	NULL

Cell	NULL
78:211-223	NULL
.	NULL

14	NULL
.	NULL

Gerster	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
Thali	NULL
,	NULL
J.	NULL
Jiricay	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1987	NULL
.	NULL

Coll	NULL
type-specificity	NULL
elements	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
enhancer	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:1323-1330	NULL
.	NULL

15	NULL
.	NULL

Gerster	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
herpesvirus	NULL
trans-activating	NULL
protein	NULL
interacts	NULL
with	NULL
transcription	NULL
factor	NULL
OTF-1	NULL
and	NULL
other	NULL
cellular	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:6347-6451	NULL
.	NULL

16	NULL
.	NULL

Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
O.	NULL
Georgiev	NULL
,	NULL
H.	NULL
van	NULL
Leeuwen	NULL
,	NULL
P.	NULL
van	NULL
der	NULL
Vliet	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
B	NULL
cell	NULL
coactivator	NULL
Bob1	NULL
shows	NULL
DNA	NULL
sequence	NULL
depen-	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

dent	NULL
complex	NULL
formation	NULL
with	NULL
Oct-1/Oct-2	NULL
factors	NULL
,	NULL
leading	NULL
to	NULL
differential	NULL
promoter	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:2781-2790	NULL
.	NULL

Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Knoepfel	NULL
,	NULL
O.	NULL
Georgiev	NULL
,	NULL
W.	NULL
Schaffner	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Hovens	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
B-cell	NULL
coactivator	NULL
of	NULL
octamer-binding	NULL
transcription	NULL
factors	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
373:360-362	NULL
.	NULL

Herr	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Cleary	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
POU	NULL
domain	NULL
:	NULL
versatility	NULL
in	NULL
transcriptional	NULL
regulation	NULL
by	NULL
a	NULL
flexible	NULL
two-in-one	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1679-1693	NULL
.	NULL

Hsieh	NULL
,	NULL
C.-L.	NULL
,	NULL
R.	NULL
Sturm	NULL
,	NULL
W.	NULL
Herr	NULL
,	NULL
and	NULL
U.	NULL
Francke	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
gene	NULL
for	NULL
the	NULL
ubiquitous	NULL
octamer-binding	NULL
protein	NULL
Oct-1	NULL
is	NULL
on	NULL
human	NULL
chromosome	NULL
1	NULL
,	NULL
region	NULL
cen-q32	NULL
,	NULL
and	NULL
near	NULL
Ly-22	NULL
and	NULL
Ltw-4	NULL
on	NULL
mouse	NULL
chromosome	NULL
1	NULL
.	NULL

Genomics	NULL
6:666-672	NULL
.	NULL

Huang	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
control	NULL
of	NULL
transcription	NULL
by	NULL
homologous	NULL
homeodomain	NULL
coregulators	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2967-2976	NULL
.	NULL

Ingraham	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
R.	NULL
Chen	NULL
,	NULL
H.	NULL
J.	NULL
Mangalam	NULL
,	NULL
H.	NULL
P.	NULL
Elsholtz	NULL
,	NULL
S.	NULL
E.	NULL
Flynn	NULL
,	NULL
C.	NULL
R.	NULL
Lin	NULL
,	NULL
D.	NULL
M.	NULL
Simmons	NULL
,	NULL
L.	NULL
Swanson	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
tissue-specific	NULL
transcription	NULL
factor	NULL
containing	NULL
a	NULL
homeodomain	NULL
specifies	NULL
a	NULL
pituitary	NULL
phenotype	NULL
.	NULL

Cell	NULL
55:519-529	NULL
.	NULL

Kim	NULL
,	NULL
U.	NULL
,	NULL
X.-F.	NULL
Qin	NULL
,	NULL
S.	NULL
Gong	NULL
,	NULL
S.	NULL
Stevens	NULL
,	NULL
Y.	NULL
Luo	NULL
,	NULL
M.	NULL
Nussenzweig	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
B-cell-specific	NULL
transcription	NULL
coactivator	NULL
OCA-B/OBF-1/	NULL
Bob-1	NULL
is	NULL
essential	NULL
for	NULL
normal	NULL
production	NULL
of	NULL
immunoglobulin	NULL
isotypes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
383:542-547	NULL
.	NULL

Klemm	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
M.	NULL
A.	NULL
Rould	NULL
,	NULL
R.	NULL
Aurora	NULL
,	NULL
W.	NULL
Herr	NULL
,	NULL
and	NULL
C.	NULL
O.	NULL
Pabo	NULL
.	NULL

1994	NULL
.	NULL

Crystal	NULL
structure	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
bound	NULL
to	NULL
an	NULL
octamer	NULL
site	NULL
:	NULL
DNA	NULL
recognition	NULL
with	NULL
tethered	NULL
DNA-binding	NULL
modules	NULL
.	NULL

Cell	NULL
77:21-32	NULL
.	NULL

Kristie	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
J.	NULL
H.	NULL
LeBowitz	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
octamer-binding	NULL
proteins	NULL
form	NULL
multi-protein-DNA	NULL
complexes	NULL
with	NULL
the	NULL
HSV	NULL
«	NULL
TIF	NULL
regulatory	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:4229-4238.	NULL
.	NULL

Lai	NULL
,	NULL
J.-S.	NULL
,	NULL
M.	NULL
A.	NULL
Cleary	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
single	NULL
amino	NULL
acid	NULL
exchange	NULL
transfers	NULL
VP16-induced	NULL
positive	NULL
control	NULL
from	NULL
the	NULL
Oct-1	NULL
to	NULL
the	NULL
Oct-2	NULL
homeo	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

62058-2065	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

Protcin-binding	NULL
sites	NULL
in	NULL
Ig	NULL
gene	NULL
enhancers	NULL
determine	NULL
transcriptional	NULL
activity	NULL
and	NULL
inducibility	NULL
.	NULL

Science	NULL
236:1573-1577	NULL
.	NULL

Li	NULL
,	NULL
P.	NULL
,	NULL
X	NULL
.	NULL

He	NULL
,	NULL
M.	NULL
R.	NULL
Gerrero	NULL
,	NULL
M.	NULL
Mok	NULL
,	NULL
A.	NULL
Aggarwal	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1993	NULL
.	NULL

Spacing	NULL
and	NULL
orientation	NULL
of	NULL
bipartite	NULL
DNA-binding	NULL
motifs	NULL
as	NULL
potential	NULL
functional	NULL
determinants	NULL
for	NULL
POU	NULL
domain	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2483-2496	NULL
.	NULL

Lobo	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
N.	NULL
Hernandez	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
7	NULL
bp	NULL
mutation	NULL
converts	NULL
a	NULL
human	NULL
RNA	NULL
polymerase	NULL
II	NULL
snRNA	NULL
promoter	NULL
into	NULL
a	NULL
RNA	NULL
polymerase	NULL
III	NULL
promoter	NULL
.	NULL

Cell	NULL
58:55-67	NULL
.	NULL

Luo	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Fujii	NULL
,	NULL
T.	NULL
Gerster	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
B	NULL
cell-derived	NULL
coactivator	NULL
potentiates	NULL
the	NULL
activation	NULL
of	NULL
immunoglobulin	NULL
promoters	NULL
by	NULL
octamer-binding	NULL
transcription	NULL
factors	NULL
.	NULL

Cell	NULL
71:231-241	NULL
.	NULL

Luo	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
,	NULL
functional	NULL
characterization	NULL
,	NULL
and	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
the	NULL
B-cell-specific	NULL
transcriptional	NULL
coactivator	NULL
OCA-B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

154115-4124	NULL
.	NULL

Misra	NULL
,	NULL
V.	NULL
,	NULL
S.	NULL
Walker	NULL
,	NULL
P.	NULL
Yang	NULL
,	NULL
S.	NULL
Hayes	NULL
,	NULL
and	NULL
P.	NULL
O'Hare	NULL
.	NULL

1996	NULL
.	NULL

Conformational	NULL
alteration	NULL
of	NULL
Oct-1	NULL
upon	NULL
DNA	NULL
binding	NULL
dictates	NULL
selectivity	NULL
in	NULL
differential	NULL
interactions	NULL
with	NULL
related	NULL
transcriptional	NULL
coactivators	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:4404-4413	NULL
.	NULL

Mittal	NULL
,	NULL
V.	NULL
,	NULL
M.	NULL
A.	NULL
Cleary	NULL
,	NULL
W.	NULL
Herr	NULL
,	NULL
and	NULL
N.	NULL
Hernandez	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
Oct-1	NULL
POU-specific	NULL
domain	NULL
can	NULL
stimulate	NULL
small	NULL
nuclear	NULL
RNA	NULL
gene	NULL
transcription	NULL
by	NULL
stabilizing	NULL
the	NULL
basal	NULL
transcription	NULL
complex	NULL
SNAP	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1955-1965	NULL
.	NULL

Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
S.	NULL
Ruppert	NULL
,	NULL
W.	NULL
Schaffner	NULL
,	NULL
and	NULL
P.	NULL
Matthias	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
cloned	NULL
octamer	NULL
transcription	NULL
factor	NULL
stimulates	NULL
transcription	NULL
from	NULL
lymphoid-specific	NULL
promoters	NULL
in	NULL
non-B	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
336:544-551	NULL
.	NULL

Nicholls	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
and	NULL
B.	NULL
Honig	NULL
.	NULL

1991	NULL
.	NULL

Protein	NULL
folding	NULL
and	NULL
associa-tion	NULL
:	NULL
insights	NULL
from	NULL
the	NULL
interfacial	NULL
and	NULL
thermodynamic	NULL
properties	NULL
of	NULL
hydro-carbons	NULL
.	NULL

Protein	NULL
Struct	NULL
.	NULL

Funct	NULL
.	NULL

Genet	NULL
.	NULL

11:281-293	NULL
.	NULL

O'Hare	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
R.	NULL
Goding	NULL
,	NULL
and	NULL
A.	NULL
Haigh	NULL
.	NULL

1988	NULL
.	NULL

Direct	NULL
combinatorial	NULL
interaction	NULL
between	NULL
a	NULL
herpes	NULL
simplex	NULL
virus	NULL
regulatory	NULL
protein	NULL
and	NULL
a	NULL
cellular	NULL
octamer-binding	NULL
factor	NULL
mediates	NULL
specific	NULL
induction	NULL
of	NULL
virus	NULL
immediate-early	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:4231-4238	NULL
.	NULL

O'Hare	NULL
,	NULL
P.	NULL
1993	NULL
.	NULL

The	NULL
virion	NULL
transactivator	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
.	NULL

Semin	NULL
.	NULL

Virol	NULL
.	NULL

4145-155	NULL
.	NULL

Pfisterer	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Annweiler	NULL
,	NULL
C.	NULL
Ullmer	NULL
,	NULL
L	NULL
,	NULL
M.	NULL
Corcoran	NULL
,	NULL
and	NULL
T.	NULL
Wirth	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
transactivation	NULL
potential	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
is	NULL
determined	NULL
by	NULL
additional	NULL
B	NULL
cell-specific	NULL
activities	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:1654-1663	NULL
.	NULL

Pierani	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
H.	NULL
Fujii	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
octamer-containing	NULL
promoters	NULL
by	NULL
either	NULL
octamer-binding	NULL
transcription	NULL
factor	NULL
1	NULL
(	NULL
OTF-1	NULL
)	NULL
or	NULL
OTF-2	NULL
and	NULL
requirement	NULL
of	NULL
an	NULL
additional	NULL
B-cell-specific	NULL
component	NULL
for	NULL
optimal	NULL
transcription	NULL
of	NULL
immunoglobulin	NULL
promoters	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6204-6215	NULL
.	NULL

Pierre-Louis	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

Unpublished	NULL
results	NULL
.	NULL

Pomerantz	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
T.	NULL
M.	NULL
Kristie	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

Recognition	NULL
of	NULL
the	NULL
surface	NULL
of	NULL
a	NULL
homeo	NULL
domain	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2047-2057	NULL
.	NULL

Pomerantz	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
C.	NULL
O.	NULL
Pabo	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1995	NULL
.	NULL

Analysis	NULL
of	NULL
homeodomain	NULL
function	NULL
by	NULL
structure-based	NULL
design	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:9752-9756	NULL
.	NULL

Ryan	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1997	NULL
.	NULL

POU	NULL
domain	NULL
family	NULL
values	NULL
:	NULL
flexi-bility	NULL
,	NULL
partnerships	NULL
and	NULL
developmental	NULL
codes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:1207-1225	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

S1	NULL
.	NULL

Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Cromlish	NULL
,	NULL
T.	NULL
Gerster	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
C.-G.	NULL
Balmaceda	NULL
,	NULL
R.	NULL
A.	NULL
Currie	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
human	NULL
lymphoid-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
immunoglobulin	NULL
genes	NULL
is	NULL
a	NULL
homeobox	NULL
protein	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
336:551-557	NULL
.	NULL

Schubart	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
A.	NULL
Rolink	NULL
,	NULL
M.	NULL
H.	NULL
Kosco-Vilbois	NULL
,	NULL
F.	NULL
Botteri	NULL
,	NULL
and	NULL
P.	NULL
Matthias	NULL
.	NULL

1996	NULL
.	NULL

B-cell-specific	NULL
coactivator	NULL
OBF-1/0CA-B/Bob1	NULL
required	NULL
for	NULL
immune	NULL
response	NULL
and	NULL
germinal	NULL
centre	NULL
formation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
383:538-542	NULL
.	NULL

Starr	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
D.	NULL
K.	NULL
Hawley	NULL
.	NULL

1991	NULL
.	NULL

TFIID	NULL
binds	NULL
in	NULL
the	NULL
major	NULL
groove	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

Cell	NULL
67:1231-1240	NULL
.	NULL

Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
T.	NULL
Wirth	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
lymphoid-specific	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323:640-643	NULL
.	NULL

Stern	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Tanaka	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
Oct-1	NULL
homeodomain	NULL
directs	NULL
formation	NULL
of	NULL
a	NULL
multiprotein-DNA	NULL
complex	NULL
with	NULL
the	NULL
HSV	NULL
transactivator	NULL
VP16	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
341:624-630	NULL
.	NULL

Strubin	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
W.	NULL
Newell	NULL
,	NULL
and	NULL
P.	NULL
Matthias	NULL
.	NULL

1995	NULL
.	NULL

OBF-1	NULL
,	NULL
a	NULL
novel	NULL
B	NULL
cell-specific	NULL
coactivator	NULL
that	NULL
stimulates	NULL
immunoglobulin	NULL
promoter	NULL
activity	NULL
through	NULL
association	NULL
with	NULL
octamer-binding	NULL
proteins	NULL
.	NULL

Cell	NULL
80:497-506	NULL
.	NULL

Sturm	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
G.	NULL
Das	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
ubiquitous	NULL
octamer-binding	NULL
protein	NULL
Oct-1	NULL
contains	NULL
a	NULL
POU	NULL
domain	NULL
with	NULL
a	NULL
homeo	NULL
box	NULL
subdomain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

21582-1599	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
W.	NULL
M.	NULL
Clouston	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
Oct-2	NULL
glutamine-rich	NULL
and	NULL
proline-rich	NULL
activation	NULL
domains	NULL
can	NULL
synergize	NULL
with	NULL
each	NULL
other	NULL
or	NULL
duplicates	NULL
of	NULL
themselves	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6046-6055	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
U.	NULL
Grossniklaus	NULL
,	NULL
W.	NULL
Herr	NULL
,	NULL
and	NULL
N.	NULL
Hernandez	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
U2	NULL
snRNA	NULL
promoter	NULL
by	NULL
the	NULL
octamer	NULL
motif	NULL
defines	NULL
a	NULL
new	NULL
class	NULL
of	NULL
RNA	NULL
52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

Oct-1-OCA¥-B	NULL
COREGULATORY	NULL
FUNCTION	NULL
-	NULL
7305	NULL
polymerase	NULL
II	NULL
enhancer	NULL
elements	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1764-1778	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
transcriptional	NULL
activation	NULL
by	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
:	NULL
interdependent	NULL
activation	NULL
domains	NULL
induce	NULL
Oct-2	NULL
phosphor-ylation	NULL
.	NULL

Cell	NULL
60:375-386	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
J.-S.	NULL
Lai	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1992	NULL
.	NULL

Promoter-selective	NULL
activation	NULL
domains	NULL
in	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
direct	NULL
differential	NULL
activation	NULL
of	NULL
an	NULL
snRNA	NULL
and	NULL
mRNA	NULL
promoter	NULL
.	NULL

Cell	NULL
68:755-767	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1992	NULL
.	NULL

Anatomy	NULL
of	NULL
an	NULL
enhancer	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

8:232-236.	NULL
van	NULL
Leeuwen	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
M.	NULL
J.	NULL
Strating	NULL
,	NULL
M.	NULL
Cox	NULL
,	NULL
R.	NULL
Kaptein	NULL
,	NULL
and	NULL
P.	NULL
C.	NULL
van	NULL
der	NULL
Vliet	NULL
.	NULL

1995	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
Oct-1	NULL
pou-specific	NULL
recognition	NULL
helix	NULL
leads	NULL
to	NULL
altered	NULL
DNA	NULL
binding	NULL
and	NULL
influences	NULL
enhancement	NULL
of	NULL
adenovirus	NULL
DNA	NULL
rep-lication	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23:3189-3197	NULL
.	NULL

Walker	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Hayes	NULL
,	NULL
and	NULL
P.	NULL
O'Hare	NULL
.	NULL

1994	NULL
.	NULL

Site-specific	NULL
conformational	NULL
alteration	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-DNA	NULL
complex	NULL
as	NULL
the	NULL
basis	NULL
for	NULL
differential	NULL
recognition	NULL
by	NULL
Vmw65	NULL
(	NULL
VP16	NULL
)	NULL
.	NULL

Cell	NULL
79:841-852	NULL
.	NULL

Wilson	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
K.	NULL
LaMarco	NULL
,	NULL
M.	NULL
G.	NULL
Peterson	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
VP16	NULL
accessory	NULL
protein	NULL
HCF	NULL
is	NULL
a	NULL
family	NULL
of	NULL
polypeptides	NULL
processed	NULL
from	NULL
a	NULL
large	NULL
precursor	NULL
protein	NULL
.	NULL

Cell	NULL
74:115-125	NULL
.	NULL

Wilson	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
R.	NULL
N.	NULL
Freiman	NULL
,	NULL
H.	NULL
Goto	NULL
,	NULL
T.	NULL
Nishimoto	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1997	NULL
.	NULL

VP16	NULL
targets	NULL
an	NULL
amino-terminal	NULL
domain	NULL
of	NULL
HCF	NULL
involved	NULL
in	NULL
cell	NULL
cycle	NULL
pro-gression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:6139-6146	NULL
.	NULL

Wirth	NULL
,	NULL
T.	NULL
,	NULL
L.	NULL
Staudt	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
octamer	NULL
oligonucleotide	NULL
upstream	NULL
of	NULL
a	NULL
TATA	NULL
motif	NULL
is	NULL
sufficient	NULL
for	NULL
lymphoid-specific	NULL
promoter	NULL
ac-tivity	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
329:174-178	NULL
.	NULL

